ASSET PURCHASE AGREEMENT DATED AS OF JUNE 20, 2008 BETWEEN ICAD, INC. (“BUYER”) AND 3TP LLC (D/B/A CAD SCIENCES) (“SELLER”)
Exhibit
2.1
EXECUTION
COPY
DATED
AS
OF JUNE 20, 2008
BETWEEN
ICAD,
INC.
(“BUYER”)
AND
3TP
LLC
(D/B/A CAD SCIENCES)
(“SELLER”)
TABLE
OF CONTENTS
Page
|
||
1.
|
Certain
Definitions
|
1
|
2.
|
Sale
and Purchase of Purchased Assets.
|
8
|
2.1
|
Purchased
Assets
|
8
|
2.2
|
Excluded
Assets
|
9
|
2.3
|
Assumption
of Certain Liabilities
|
10
|
2.4
|
Non-Assumption
of Liabilities
|
10
|
3.
|
Closing;
Purchase Price
|
11
|
3.1
|
Closing
|
11
|
3.2
|
Purchase
Price
|
12
|
3.3
|
Escrow
|
12
|
3.4
|
Purchase
Price Allocation
|
12
|
4.
|
Representations,
Warranties and Covenants of Seller
|
12
|
4.1
|
Due
Organization and Qualification; Subsidiaries
|
12
|
4.2
|
Authority
to Execute and Perform Agreement
|
13
|
4.3
|
Financial
Statements
|
13
|
4.4
|
No
Material Adverse Change
|
14
|
4.5
|
Tax
Matters.
|
14
|
4.6
|
Compliance
with Laws
|
14
|
4.7
|
Permits
|
15
|
4.8
|
No
Breach
|
15
|
4.9
|
Consents
and Approvals
|
15
|
4.10
|
Judgments
and Proceedings
|
15
|
4.11
|
Contracts
|
16
|
4.12
|
Real
Property.
|
16
|
4.13
|
Books
of Account and Reports
|
17
|
4.14
|
Tangible
Property
|
17
|
4.15
|
Intangibles.
|
17
|
4.16
|
Title
|
21
|
4.17
|
Indebtedness
|
21
|
4.18
|
Undisclosed
Liabilities
|
21
|
4.19
|
Suppliers
and Customers
|
21
|
4.20
|
Potential
Conflicts of Interest
|
21
|
4.21
|
Product
Warranty
|
21
|
4.22
|
Inventory
|
22
|
4.23
|
FDA
Qualification and Approvals.
|
22
|
4.24
|
Related
Party Transactions
|
23
|
4.25
|
No
Broker
|
23
|
4.26
|
Investment
Matters
|
23
|
4.27
|
Full
Disclosure
|
24
|
5.
|
Representations
and Warranties of Buyer
|
24
|
5.1
|
Due
Incorporation and Qualification
|
24
|
5.2
|
Authority
to Execute and Perform Agreement
|
24
|
5.3
|
No
Breach
|
25
|
i
Page
5.4
|
No
Broker
|
25
|
5.5
|
Capitalization
|
25
|
5.6
|
Tax
Matters
|
25
|
5.7
|
Issuance
of Buyer’s Stock
|
25
|
5.8
|
Filings,
Consents and Approvals
|
26
|
5.9
|
Regulatory
Compliance
|
26
|
5.10
|
No
Buyer Material Adverse Change
|
26
|
5.11
|
Compliance
with Laws
|
26
|
6.
|
Deliveries
by Seller
|
26
|
7.
|
Deliveries
by Buyer
|
27
|
8.
|
Covenants
and Agreements
|
28
|
8.1
|
Certain
Pre-Closing Covenants
|
28
|
8.2
|
Notice
of Developments
|
30
|
8.3
|
No
Solicitation of Transactions
|
30
|
8.4
|
Employee
Matters.
|
30
|
8.5
|
Pre-Closing
Tax Returns
|
31
|
8.6
|
Cooperation
on Tax Matters
|
31
|
8.7
|
Legal
Conditions to Transaction
|
31
|
8.8
|
Form
8-K Obligations
|
32
|
8.9
|
Use
of Names
|
32
|
8.10
|
Contract
Matters
|
32
|
8.11
|
Sale
of Shares Pursuant to Rule 144 by the Seller
|
33
|
8.12
|
Accounts
Receivable
|
33
|
8.13
|
Server
Agreement
|
33
|
8.14
|
Employee
Laptop Computers
|
34
|
9.
|
Conditions
to Closing.
|
34
|
9.1
|
Conditions
to Obligations of Buyer
|
34
|
9.2
|
Conditions
to Obligations of Seller
|
35
|
10.
|
Interpretation
and Survival of Representations and Warranties
|
36
|
11.
|
Indemnification.
|
36
|
11.1
|
Obligation
of Seller to Indemnify
|
36
|
11.2
|
Obligation
of Buyer to Indemnify
|
37
|
11.3
|
Third
Party Claims
|
37
|
11.4
|
Limitation
of Liability
|
38
|
11.5
|
Satisfaction
of Seller Losses
|
38
|
11.6
|
Assistance
|
38
|
12.
|
Expenses
|
38
|
13.
|
Termination
and Abandonment.
|
38
|
13.1
|
Ability
to Terminate
|
38
|
13.2
|
Effect
of Termination
|
39
|
14.
|
Further
Assurances.
|
39
|
15.
|
Confidentiality
|
40
|
16.
|
Non-Compete.
|
40
|
17.
|
Bulk
Sales Compliance
|
41
|
ii
Page
18.
|
Miscellaneous.
|
41
|
18.1
|
Publicity
|
41
|
18.2
|
Notices
|
41
|
18.3
|
Entire
Agreement
|
42
|
18.4
|
Waivers
and Amendments
|
42
|
18.5
|
Binding
Agreement
|
43
|
18.6
|
Governing
Law
|
43
|
18.7
|
Assignment
|
43
|
18.8
|
Variations
in Pronouns
|
43
|
18.9
|
Disclosure
Schedules
|
43
|
18.10
|
Severability
|
43
|
18.11
|
Counterparts
|
43
|
18.12
|
Exhibits
and Schedules
|
43
|
18.13
|
Headings
|
43
|
18.14
|
Consent
to Jurisdiction and Service of Process
|
43
|
EXHIBIT
|
DESCRIPTION
|
Exhibit
A
|
Escrow
Agreement
|
Exhibit
B
|
Xxxx
of Sale
|
Exhibit
C
|
Master
Trademark Assignment Agreement
|
Exhibit
D
|
Master
Patent Assignment Agreement
|
Exhibit
E
|
510(k)
Clearances Assignment Agreement
|
Exhibit
F
|
Assignment
and Assumption Agreement
|
iii
SCHEDULES
SCHEDULE
|
DESCRIPTION
|
2.1(5)
|
Assumed
Contracts
|
2.2(8)
|
Excluded
Assets
|
2.3(2)
|
Assumed
Warranty and Service Obligations
|
2.3(3)
|
Specified
Liabilities
|
3.4
|
Purchase
Price Allocation
|
4.1
|
Due
Incorporation and Qualification; Subsidiaries
|
4.3
|
Financial
Statements
|
4.4
|
No
Material Adverse Change
|
4.5
|
Taxes
|
4.6
|
Compliance
with Laws
|
4.7
|
Permits
|
4.8
|
No
Breach
|
4.9
|
Consents
and Approvals
|
4.10
|
Judgments
and Proceedings
|
4.11
|
Contracts
|
4.12
|
Real
Property
|
4.14
|
Tangible
Property
|
4.15
|
Intangibles
|
4.16
|
Title
|
4.17
|
Indebtedness
|
4.19
|
Suppliers
and Customers
|
4.22
|
Inventory
|
4.23
|
Regulatory
Matters
|
4.24
|
Related
Party Transactions
|
4.25
|
No
Broker
|
8.4
|
Transferred
Employees
|
9.1(8)
|
Required
Consents
|
iv
AGREEMENT
(the “Agreement”), dated as of June 20, 2008, by and between iCAD, Inc., a
Delaware corporation (“Buyer”) and 3TP LLC (d/b/a CAD Sciences), a New York
limited liability company (“Seller”).
Background
WHEREAS,
Seller is engaged in the business of developing and commercializing products
that perform computer assisted modeling of contrast enhancement in diagnostic
image modalities and providing services with respect thereto (the “Business”);
and
WHEREAS,
Buyer desires to acquire substantially all of the assets of Seller used in
connection with the Business and to assume certain of Seller’s liabilities in
connection therewith, and Seller desires to sell such assets and transfer such
specified liabilities to Buyer, all upon the terms and subject to the conditions
hereinafter set forth.
NOW,
THEREFORE, in consideration of the mutual agreements and covenants contained
herein, and intending to be legally bound, the parties agree as
follows:
1. Certain
Definitions.
For
purposes of this Agreement, except as otherwise expressly provided or unless
the
context otherwise requires, (1) the terms defined in this Section have the
meanings assigned to them in this Section, wherever they appear in this
Agreement (2) all accounting terms not otherwise defined herein have the
meanings assigned under generally accepted accounting principles consistently
applied and as in effect on the date hereof (“GAAP”) and (3) all words
“herein,” “hereof” and “hereunder” and other words of similar import refer to
this Agreement as a whole and not to any particular Section or other
subdivision.
“Affiliate”
means,
with respect to a specified Person, any other Person that directly or indirectly
through one or more intermediaries controls, is controlled by, or is under
common control with, the specified Person.
“Agreement”
has
the
meaning set forth in the introduction.
“Approval”
has
the
meaning set forth in Section 8.7.
“Assumed
Contract”
has
the
meaning set forth in Section 2.1(5).
“Business”
has
the
meaning set forth in the recitals.
“Buyer”
has
the
meaning set forth in the introduction.
“Buyer
Indemnified Parties”
has
the
meaning set forth in Section 11.1
“Buyer
Material Adverse Effect”
means
a
material adverse effect on the business, properties, assets or financial
condition of Buyer and its Subsidiaries, taken as a whole, other than (i)
effects resulting from the execution or announcement of this Agreement or any
other Transaction Document or resulting from or relating to compliance with
the
terms of, or the taking of any action required by, this Agreement or any other
Transaction Document, (ii) effects of any change arising in connection with
acts
of war, sabotage, terrorism, military actions or the escalation thereof, (iii)
effects of any change in applicable Laws, regulations or accounting rules,
(iv)
changes in general economic, financial, regulatory, political or market
conditions in the world and (v) changes in conditions or developments generally
applicable to the industries in which Buyer is involved and that do not affect
Buyer in any manner materially disproportionate to other Persons in such
industry.
“Buyer’s
Stock”
means
shares of common stock, par value $0.01 per share, of iCAD, Inc.
“CAD
Products”
has
the
meaning set forth in Section 2.1(1).
“Closing”
means
the closing of the transactions contemplated by this Agreement.
“Closing
Date”
means
the date on which the Closing occurs.
“Code”
means
the Internal Revenue Code of 1986, as amended.
“Confidentiality
Agreement”
has
the
meaning set forth in Section 15.
“Consent”
means
any consent, approval, order or authorization of, or any declaration, filing
or
registration with, or any application or report to, or any waiver by, or any
other action (whether similar or dissimilar to any of the foregoing) of, by
or
with, any Person, which is necessary in order to take a specified action or
actions in a specified manner and/or to achieve a specified result or to avoid
the occurrence of a default.
“Contract”
means
any written contract, agreement, instrument, order, commitment or binding
arrange-ment, express or implied, of any nature whatsoever.
“Contract
Right”
means
any right, power or remedy under any Contract, including but not limited to
rights to receive property or services or otherwise to derive benefits from
the
payment, satisfaction or performance of another party’s
obligations.
“Documents”
means
and includes any document, agreement, instru-ment, certificate, notice, Consent,
affidavit, correspondence (by letter, electronic mail, telex or otherwise),
written statement, schedule or exhibit whatsoever.
“Domain
Names”
has
the
meaning set forth in Section 4.15(11).
“Employee
Benefit Plan”
means
any employee benefit plan as defined in Section 3(3) of ERISA, any “voluntary
employees’ beneficiary association” within the meaning of Section 501(c)(9) of
the Code, “welfare benefit fund” within the meaning of Section 419 of the Code,
or “qualified asset account” within the meaning of Section 419A of the Code, and
any other plan, program, policy or arrangement for or regarding bonuses,
commissions, incentive compensation, severance, vacation, deferred compensation,
pensions, profit sharing, retirement, payroll savings, stock options, stock
purchases, stock awards, stock ownership, phantom stock, stock appreciation
rights, equity compensation, medical/dental expense payment or reimbursement,
disability income or protection, sick pay, group insurance, self insurance,
death benefits, employee welfare or fringe benefits of any nature, including
those benefiting retirees or former employees.
2
“Encumbrance”
means
any lien, security interest, pledge, mortgage, easement, leasehold, assessment,
covenant, restriction, hypothecation or any other encumbrance, claim, burden
or
charge of any kind or nature whatsoever.
“ERISA
Affiliate”
means
any entity, trade or business (whether or not incorporated) that is part of
the
same controlled group with, common control with, part of an affiliated service
group with, or part of another arrangement that includes, Seller or any ERISA
Affiliate within the meaning of Code Section 414(b), (c), (m) or (o).
“Escrow
Agent”
has
the
meaning set forth in Section 3.3.
“Escrow
Agreement”
has
the
meaning set forth in Section 3.3.
“Escrow
Shares”
has
the
meaning set forth in Section 3.3.
“Exchange
Act”
means
the Securities Exchange Act of 1934, as amended.
“Excluded
Assets”
has
the
meaning set forth in Section 2.2.
“FDA”
means
the United States Food and Drug Administration.
“FDCA”
means
the Federal Food, Drug, and Cosmetic Act of 1938, as amended.
“Financial
Statements”
has
the
meaning set forth in Section 4.3.
“Fundamental
Representations”
has
the
meaning set forth in Section 10.1.
“GAAP”
has
the
meaning set forth in Section 1.
“Indebtedness”
means
all items which, in accordance with GAAP, would be included in determining
total
liabilities as shown on the liability side of a balance sheet as of the date
Indebtedness is to be determined.
“Insurance
Policies”
means
any policy or binder for fire, public liability, product liability, general
liability, life, hospital, medical, disability, comprehensive, automobile,
property damage, workmen’s compensation, key man, fidelity bond, theft, forgery,
vehicular, or errors and omissions insurance, or for any other insurance of
any
nature whatsoever.
3
“Intangible”
means,
throughout the world, any name, corporate name, domain name, fictitious name,
Domain Name, trademark, trademark application, trademark registration, service
xxxx, service xxxx application, service xxxx registration, trade name, brand
name, product name, corporate name, symbol, logo, slogan, trade dress, trade
secret, know-how, research and development data, written works, visual works,
audio works, multimedia works, Web site, database, information or data created
or maintained in any database, technical information or data, design, formula,
invention, product right, technology, idea, concept, method, process, discovery,
Software, license, Permit, or other intangible asset of any nature, whether
in
use, operational, active, under development or design, non-operative, or
inactive, owned, marketed, maintained, supported, used, licensed or otherwise
held for use by, or licensed to or with respect to which rights are granted
to,
a Person, whether arising under statutory or common law in any jurisdiction
or
otherwise, and includes, without limitation, the goodwill of the business
symbolized by and associated with such name, corporate name, domain name,
fictitious name, Domain Name, trademark, service xxxx, trade name, brand name,
product name, symbol, logo, slogan, or trade dress, including without limitation
all CAD Products which comprise intangible property, and any and all
Intellectual Property Rights in and to the foregoing.
“Intellectual
Property Right(s)”
means
any and all intellectual property rights and industrial property rights arising
under statutory or common law, contract, or otherwise, and whether or not
perfected, including all: (a) Patents; (b) rights associated with works of
authorship including copyrights, moral rights, copyright applications, copyright
registrations, and rights to prepare derivative works; (c) rights relating
to trade secrets and confidential information; (d) rights in trademarks,
trademark applications, service marks, service xxxx applications, trade names,
logos, symbols, and the like, including all goodwill therein;
(e) divisions, continuations, renewals, reissues and extensions of the
foregoing (as and to the extent applicable) now existing, hereafter filed,
issued, or acquired; and (f) rights analogous to those set forth in this
“Intellectual Property Rights” definition and any and all other proprietary
rights relating to the foregoing in any jurisdiction throughout the world,
including all rights to xxx for past, present and future
infringement.
“Interim
Balance Sheet”
has
the
meaning set forth in Section 4.3.
“Inventory”
means
any raw materials, supplies, work-in-progress, finished goods, parts or any
other inventory of any nature whatsoever used in connection with the Business.
“IRS”
means
the Internal Revenue Service.
“Judgment”
means
any order, writ, injunction, fine, citation, award, decree or any other judgment
of any kind whatsoever of any foreign, federal, state or local court,
governmental body, administrative agency, regulatory authority or arbitration
tribunal.
“Knowledge
of Seller”
or
phrases of similar import means, with respect to Seller, the actual knowledge
of
the officers and members of the board of managers of Seller after due inquiry
of
those individuals responsible for the matter being represented and warranted.
“Laws”
means
any applicable laws relating to the operation of the Business, including but
not
limited to, medical device product distribution, and the possession, control,
warehousing, marketing, sale and distribution of medical devices, the FDCA,
Current Good Manufacturing Practices (CGMP), requirements of the Quality System
regulation for medical devices, as specified in Title 21, code of Federal
Regulations, Part 820 (21 C.F.R. 820), the Occupational Health and Safety Act
(29 U.S.C. Section 651 et seq.) or other applicable state or federal laws and
any similar laws and regulations issued by foreign regulatory bodies and any
implementing regulations to any of the foregoing.
4
“Liabilities”
means
any direct or indirect Indebtedness, liability, claim, loss, damage, Judgment,
deficiency or obligation, known or unknown, fixed or inchoate, liquidated or
unliquidated, secured or unsecured, accrued, absolute, contingent or otherwise
whether or not of a kind required by GAAP to be set forth on financial
statements.
“Losses”
means
any and all Liabilities, Proceedings, causes of action, costs and expenses
including, without limitation, costs of investigation, actual interest costs,
penalties and attorneys’ fees associated with the enforcement of any terms and
conditions of this Agreement.
“Material
Permits”
has
the
meaning set forth in Section 4.7.
“OSS”
has
the
meaning set forth in Section 4.15(5).
“Patents”
means
all patents and patent applications and all patent applications hereafter filed,
including any continuation, continuation-in-part, division, provisional or
any
substitute applications, any patent issued with respect to any such patent
applications, any reissue, reexamination, renewal or extension (including any
supplemental patent certificate) of any such patent, and any confirmation patent
or registration patent or patent of addition based on any such patent, and
all
foreign counterparts of any of the foregoing.
“Permit”
means
all governmental licenses, authorizations, supplier numbers, registrations,
permits, device authorizations and approvals, certificates, franchises,
qualifications, accreditations, consents, approvals, listings, product
clearances or approvals, marketing authorizations in connection with the conduct
of Seller’s Business or to comply with applicable Laws, including, establishment
registrations, device listings, Investigational Device Exemptions (IDEs), 510(k)
exemptions, 510(k) clearances, and PMA approvals, as those terms are defined
in
the FDCA and implementing regulations, and those issued by state governments,
foreign regulatory bodies, environmental protection agency permits.
“Permitted
Encumbrances”
means,
collectively, (i) Encumbrances for Taxes, fees, levies, duties or other
governmental charges not yet past due and (ii) Encumbrances for mechanics,
material, laborers, employees, suppliers or similar liens arising by operation
of Law for sums which are not yet past due.
“Person”
means
any individual, sole proprietorship, joint venture, partnership, corporation,
limited liability company, association, joint-stock company, unincorporated
organization, cooperative, trust, estate, government entity or authority
(including any branch, subdivision or agency thereof), administrative or
regulatory authority, or any other entity of any kind or nature
whatsoever.
“Proceeding”
means
any claim, suit, action, equitable action, litigation, investigation,
arbitration, trademark opposition, cancellation action, administrative hearing
or any other judicial or administrative proceeding of any kind or nature
whatsoever, or any formal demand which might lead to any of the
foregoing.
5
“Property”
means
real, personal or mixed property.
“Public
License”
has
the
meaning set forth in Section 4.15(5).
“Purchase
Price”
has
the
meaning set forth in Section 3.2.
“Purchased
Assets”
has
the
meaning set forth in Section 2.1.
“Real
Property”
means
any real estate, land, building, structure, improvement or other real property
of any kind or nature whatsoever owned, leased or occupied by either Seller,
all
shares of stock or other ownership interests through which interests in real
estate may be held, and all appurtenant and ancillary rights thereto, including,
without limitation, easements, covenants, water rights, sewer rights and utility
rights.
“Retained
Liabilities”
has
the
meaning set forth in Section 2.4.
“SEC”
has
the
meaning set forth in Section 5.9.
“SEC
Reports”
has
the
meaning set forth in Section 5.9.
“Securities
Act”
has
the
meaning set forth in Section 5.7.
“Seller”
has
the
meaning set forth in the introduction.
“Seller
Employee Benefit Plans”
means
each
of
the Employee Benefit Plans which Seller, or any ERISA Affiliate, sponsors,
maintains or contributes to, is required to contribute to, or has or could
reasonably be expected to have any Liability of any nature with respect to,
whether known or unknown, direct or indirect, fixed or contingent, for the
benefit of present or former employees of Seller and/or its ERISA
Affiliates.
“Seller
Indemnified Parties”
has
the
meaning set forth in Section 11.2.
“Seller
Intangibles”
means
any Software or other Intangible that is used, held for use, marketed,
maintained, supported, operated, under development or design, licensed, or
with
respect to which rights are granted in connection with, related to, pursuant
to,
in the conduct of, or as part of the Business, or any Software or other
Intangible that is owned, in whole or in part, solely or jointly with one or
more other Persons, by Seller in connection with the Business.
“Seller
Material Adverse Effect”
means
a
material adverse effect on the Purchased Assets taken as a whole, other than
(i)
effects resulting from the execution or announcement of this Agreement or any
other Transaction Document or resulting from or relating to compliance with
the
terms of, or the taking of any action required by, this Agreement or any other
Transaction Document, (ii) effects of any change arising in connection with
acts
of war, sabotage, terrorism, military actions or the escalation thereof, (iii)
effects of any change in applicable Laws, regulations or accounting rules,
(iv)
changes in general economic, financial, regulatory, political or market
conditions in the world and (v) changes in conditions or developments generally
applicable to the industries in which Seller is involved and that do not affect
Seller in any manner materially disproportionate to other Persons in such
industry.
6
“Seller
Web Sites”
has
the
meaning set forth in Section 4.15(15).
“Shares”
has
the
meaning set forth in Section 3.2.
“Software”
means
any computer program, operating system, application, system, firmware or
software of any nature, whether operational, active, under development or
design, non-operational or inactive, including all object code, source code,
comment code, algorithms, processes, formulae, interfaces, navigational devices,
menu structures or arrangements, icons, operational instructions, scripts,
commands, syntax, screen designs, reports, designs, concepts, visual
expressions, technical manuals, test scripts, user manuals and other
documentation therefore, whether in machine-readable form, programming language
or any other language or symbols, and whether stored, encoded, recorded or
written on disk, tape, film, memory device, paper or other media of any nature
and all data bases necessary to operate any such computer program, operating
system, application, system, firmware or software.
“Specified
Liabilities”
has
the
meaning set forth in Section 2.3
“Subsidiaries”
with
respect to any Person, means any other Person or business entity, with respect
to whom 50% or more of the equity interest (or debt or other interest
convertible into an equity interest) is owned directly or indirectly by such
Person.
“Tangible
Property”
means
any machinery, buildings, fixtures, equipment, parts, furniture, leasehold
improvements, office equipment, vehicles, tools, forms, molds, supplies or
other
tangible property of any kind or nature whatsoever,
including without limitation all CAD Products which comprise tangible
property,.
“Tax”
or
“Taxes”
means
all taxes and governmental impositions of any kind in the nature of (or similar
to) taxes, payable to any federal, state, local or foreign taxing authority
or
other governmental authority, including, but not limited to, those on or
measured by or referred to as income, franchise, profits, gross receipts,
capital, ad valorem, custom duties, alternative or add-on minimum taxes,
estimated, environmental, disability, registration, value added, sales, use,
service, real or personal property, capital stock, license, payroll,
withholding, employment, social security, workers’ compensation, unemployment
compensation, utility, severance, production, excise, stamp, occupation,
premiums, windfall profits, transfer and gains taxes, and interest, penalties
and additions to tax imposed with respect thereto.
“Tax
Return”
shall
mean any return (including any information return), report, statement,
declaration, estimate, schedule, notice, notification, form, election,
certificate or other document or information (including any amendments thereto)
that is, has been or may in the future be filed with or submitted to, or
required to be filed with or submitted to, any governmental authority in
connection with the determination, assessment, collection or payment of any
Tax
or in connection with the administration, implementation or enforcement of
or
compliance with any Law relating to any Tax.
7
“Transaction
Documents”
means
this Agreement together with all schedules and exhibits hereto, and all other
Documents executed and delivered pursuant to this Agreement.
“Transferred
Contract”
has
the
meaning set forth in Section 8.10.
“Transferred
Employees”
has
the
meaning set forth in Section 8.4(1).
“WARN
Act”
means
the Worker Adjustment and Retraining Notification Act and all similar federal
and state Laws relating to termination of employment.
“Web”
has
the
meaning set forth in Section 4.15(15).
2. Sale
and Purchase of Purchased Assets.
2.1 Purchased
Assets.
On the
terms and subject to the conditions set forth in this Agreement, at the Closing,
Seller shall sell, transfer, convey, assign and deliver to Buyer and Buyer
shall
purchase and acquire from Seller, all right, title and interest in and to all
of
Seller’s assets which are owned or used in its operation of the Business, and
rights of every nature, kind and description wheresoever located and whether
or
not reflected on the books and records of Seller (excluding only those assets
set forth in Section 2.2) including, without limitation, the following (all
of
which being hereinafter collectively referred to as the “Purchased Assets”) free
and clear of all Encumbrances other than Permitted Encumbrances:
(1)
all
right, title and interest of Seller in and to the following products: FTP for
Breast MR, ProStream, Theramap (collectively, the “CAD Products”);
(2)
all
Intangibles owned by Seller or used in connection with the Business and all
Intellectual Property Rights associated therewith, all goodwill, licenses and
sublicenses granted or obtained with respect thereto, and rights thereunder,
remedies against infringements thereof, and rights to protection of interests
therein under the Laws of all jurisdictions;
(3)
all
of
Seller’s machinery, equipment, supplies and all other items of Tangible Property
used in the Business;
(4)
all
of
Seller’s Inventory;
(5)
all
rights, powers and privileges in and to those Contracts set forth on Schedule
2.1(5),each of which has been entered into in connection with the operation
or
conduct of the Business (collectively, the “Assumed Contracts”);
(6)
all
of
Seller’s records relating to the Business, including, correspondence, employment
records for the Transferred Employees, production records, property records,
research and development files, customer, vendor, supplier, contractor and
service provider lists and records, technical files for the CE Xxxx and FDA
approved products and copies of official notifications that the CE Xxxx and
FDA
clearances have been achieved and other records and files of or relating to
the
Business or the Purchased Assets (but excluding employment (other than those
of
Transferred Employees) and accounting records);
8
(7)
all
prototypes, archive files, physical designs, advertising and promotional
materials and other similar items used in or related to the Business that are
not Intangibles or Excluded Assets (as hereinafter defined);
(8)
all
of
Seller’s prepayments, prepaid expenses, deferred charges, advances, escrows and
deposits under any Assumed Contract;
(9)
the
name
“CAD Sciences”;
(10)
all
rights, benefits and interests relating to or arising out of any warranty,
express or implied, issued in connection with the conduct of the
Business;
(11)
all
insurance benefits, including rights and proceeds, arising from or relating
to
the Purchased Assets or the Specified Liabilities (as hereinafter defined)
prior
to the Closing Date;
(12)
all
of
Seller’s Proceedings, demands and other legal rights and remedies, whether or
not known as of the Closing, relating to Seller’s ownership of the Purchased
Assets and/or the Business, but excluding claims against Buyer with respect
to
the transactions contemplated herein; and
(13)
all
other
rights, interests, assets and items of personal property, tangible or intangible
(including goodwill), owned, used by or accruing to the benefit of Seller in
connection with the operation or conduct of the Business or necessary to enable
Buyer to continue the operation or conduct of the Business substantially as
operated or conducted by Seller immediately before the Closing
Date.
2.2 Excluded
Assets.
Notwithstanding anything to the contrary contained herein, there is excluded
from the sale and purchase contemplated by this Agreement the following assets
(the “Excluded Assets”):
(1)
the
consideration delivered by Buyer to Seller pursuant to this Agreement for the
Purchased Assets;
(2)
all
personnel records and other records that Seller is required by Law to retain
in
its possession provided that copies thereof have been furnished to Buyer (except
for records regarding employment and labor matters (other than those relating
to
Transferred Employees), membership and other equity interests in the Company,
any Retained Liability and any Excluded Asset, copies of which the Seller is
not
required to provide to the Buyer hereunder);
(3)
all
claims for refund of Taxes and other governmental charges of whatever nature
covering periods ending on or before the Closing Date;
9
(4)
all
rights of Seller under this Agreement;
(5)
all
of
Seller’s accounts receivable;
(6)
the
stock
ledger and minute books of Seller, all financial books and records of Seller
(copies of which have been delivered to Buyer) and all books and records
relating to any Excluded Asset or Retained Liability;
(7)
all
of
Seller’s cash in the bank or invested on the Closing Date, except for cash
deposits from customers and the pro rata portion of advances, advertising
payments and other amounts payable to Seller under the Assumed Contracts;
(8)
all
assets of Seller which are not used or related to the operation of the Business,
all claims for refunds under insurance policies maintained by Seller and those
other assets, properties and rights specifically listed in Schedule 2.2(8)
hereof;
2.3 Assumption
of Certain Liabilities.
On the
terms and subject to the conditions set forth herein, on the Closing Date,
Buyer
shall assume, agree to perform and agree to pay only the following Liabilities
(“Specified Liabilities”) but only to the extent the same are not incurred or
resulting from (directly or indirectly) any breach or default by Seller under
any Assumed Contract with any Person or any representation, warranty or covenant
of Seller noted herein:
(1)
all
Liabilities of Seller arising and relating to periods after the Closing in
the
nature of services to be performed, payments to be made or goods to be delivered
under the Assumed Contracts transferred pursuant to this Agreement, but not
including any Liabilities of Seller under any Contract with any Affiliate or
Principal or other member of Seller;
(2)
all
existing warranty and service obligations under the Assumed Contracts set forth
in Schedule 2.3(2); and
(3)
all
such
other Liabilities specifically assumed by Buyer on Schedule 2.3(3)
hereof.
2.4 Non-Assumption
of Liabilities.
Notwithstanding anything herein capable of interpretation to the contrary,
except for the Specified Liabilities, Buyer shall not assume and, as between
Seller and Buyer, Seller shall remain liable for all of Seller’s Liabilities
existing as of the Closing Date or thereafter whether or not disclosed to Buyer
on any Schedule hereto, and Buyer does not assume and shall in no event be
liable therefore (collectively, the “Retained Liabilities”). Such
Retained Liabilities shall include without limitation:
(1)
all
Liabilities to the extent arising out of or relating to (i) the operation or
conduct by Seller of the Business prior to the Closing Date other than as
specifically set forth in Section 2.3, (ii) any business conducted by Seller
not
relating to the Purchased Assets and (iii) all Liabilities to the extent arising
out of or relating to any Excluded Asset;
(2)
any
Liability resulting from product liability or general liability claims for
damage or injury (actual or alleged) to Persons or Property to the extent
arising from the ownership, possession or use of any product sold by Seller
prior to the Closing in excess of any reserve therefor on the Financial
Statements except that Seller shall not be liable to the extent the damage
or
injury arises out of modifications made to any such product by the Buyer or
the
failure of Buyer to properly maintain or update any such product;
10
(3)
all
Liabilities and commitments relating to current or former employees of Seller,
including without limitation (i) any compensation or benefits payable to present
or past employees of Seller, including, any Liabilities arising under any Seller
Employee Benefit Plan or other employee benefit plan and any of Seller’s
Liabilities for vacation, holiday or sick pay, and (ii) any Liabilities under
any employment, consulting or non-competition agreement, change of control
agreement, indemnity agreement, any retention or performance-based bonus or
other compensation agreement, and any similar agreements, whether written or
oral, and any Liabilities arising out of the termination by Seller of any of
its
employees in anticipation or as a consequence of, or following, consummation
of
the transactions contemplated by the Transaction Documents, including under
the
WARN Act;
(4)
all
Liabilities and commitments of Seller in respect of Taxes;
(5)
any
Liabilities arising from or relating to any environmental matters or conditions
arising on or before the Closing Date, including without limitation any release
of hazardous substances after the Closing Date arising from events or
circumstances occurring on or before the Closing Date, except to the extent
actually caused by Buyer after the Closing Date;
(6)
any
Liability of Seller to any employee or arising out of or relating to any
employee grievance, in each case to the extent arising out of or relating to
any
occurrence or event happening on or prior to the Closing Date and to any
employees of the Business for periods prior to the Closing Date;
(7)
any
Liability of Seller to any Affiliate of Seller;
(8)
all
Indebtedness obligations of Seller;
(9)
all
of
Seller’s accounts payable;
(10)
any
Liability of Seller arising out of any Proceeding pending or Judgment entered on
or prior to the Closing Date;
(11)
any
Liability of Seller arising from this Agreement or any Transaction Document
executed by Seller; and
(12)
any
other
Liabilities of Seller, its Subsidiaries or current or former Affiliates thereof,
if any, other than the Specified Liabilities.
3. Closing;
Purchase Price
3.1 Closing.
The
Closing of the transactions contemplated by this Agreement shall take place
within two (2) business days after the satisfaction of the terms and conditions
of Section 9 at the offices of Blank Rome LLP, 000 Xxxxxxxxx Xxxxxx, Xxx Xxxx,
Xxx Xxxx 00000. All transactions occurring at the Closing shall be deemed to
occur concurrently.
11
3.2 Purchase
Price.
In
consideration of the sale, transfer, conveyance and delivery of the Purchased
Assets, and in reliance upon the representations and warranties made herein
by
Seller, Buyer shall on the Closing Date, in full payment thereof, pay to Seller,
or its designees, Five Million Dollars ($5,000,000) (the “Purchase Price”)
payable as follows: (i) Two Million Dollars ($2,000,000) in immediately
available funds and (ii) the issuance of such number of restricted shares
of Buyer Stock as are equal to Three Million Dollars ($3,000,000) divided by
the
average per share closing sales price reported on the Nasdaq Capital Market
for
the ten (10) consecutive trading days ending on the trading day immediately
preceding the Closing Date (the “Shares”). The parties acknowledge and agree
that the terms of this Agreement are commercially reasonable and have been
negotiated in an arms-length transaction and that the Purchase Price constitutes
fair market value for the Purchased Assets.
3.3 Escrow.
In
order to secure Seller’s indemnification obligations under Section 11 of this
Agreement, Buyer shall, at the Closing, deliver to and deposit with U.S. Bank
National Association (the “Escrow Agent”) such number of Shares
equal to Seven Hundred Fifty Thousand Dollars ($750,000) as calculated in
Section 3.2(ii) above
(the
“Escrow Shares”). The Escrow Shares shall be held for a period of one (1) year
with (i) Escrow Shares equal to Five Hundred Thousand Dollars ($500,000) as
calculated in Section 3.2 (ii) above to be distributed by the Escrow Agent
on
the six (6) month anniversary of the Closing (subject to any claims for
indemnification) and (ii) the remaining Escrow Shares to be distributed by
the
Escrow Agent on the first anniversary of the Closing (subject to any claims
for
indemnification), all pursuant to the terms of an escrow agreement to be entered
into on the Closing Date by and among Buyer, Seller and the Escrow Agent, in
substantially the form attached hereto as Exhibit
A
(the
“Escrow Agreement”).
3.4 Purchase
Price Allocation.
The
Purchase Price for the Purchased Assets shall be allocated in a manner set
forth
on Schedule 3.4 hereto. In connection with the determination of such schedule,
the parties shall cooperate with each other and provide such information as
any
of them shall reasonably request. The parties shall (a) prepare and, where
applicable, file each report relating to the federal, state, local, foreign
and
other Tax consequences of the purchase and sale contemplated hereby (including
the filing of IRS Form 8594) in a manner consistent with such allocation
schedule and (ii) take no position in any Tax Return or other Tax filing,
Proceeding, audit or otherwise which is inconsistent with such allocation.
4. Representations,
Warranties and Covenants of Seller.
Knowing
that Buyer intends to rely thereon, Seller represents, warrants and covenants
to
Buyer as of the date hereof and as of the Closing as set forth in this Section
4
as follows:
4.1 Due
Organization and Qualification; Subsidiaries.
Seller
is a limited liability company duly organized, validly existing and in good
standing under its jurisdiction of formation. Seller has full limited liability
company power and authority to own, lease and operate the Purchased Assets,
Properties and Business, to carry on its business as and where such business
is
now conducted and to enter into and perform this Agreement and each of the
other
Transaction Documents to which it is a party and to consummate the transactions
contemplated hereby and thereby upon the terms and conditions herein and therein
provided. Except as would not reasonably be expected to have a Seller Material
Adverse Effect, Seller is duly qualified as a foreign entity in good standing
under the Laws of each jurisdiction in which its activities would require such
qualification. Except as set forth in Schedule 4.1, Seller does not own any
Subsidiaries, or own, directly or indirectly any shares of stock or other equity
interest in or control, alone or in combination with others, any Persons.
Schedule 4.1 sets forth the names and titles of Seller’s officers and directors.
Accurate and complete copies of the organizations Documents, each as amended
to
date, have been delivered to Buyer.
12
4.2 Authority
to Execute and Perform Agreement.
Seller
has all requisite power and authority and approvals required to enter into,
execute, deliver and perform this Agreement and its obligations hereunder and
to
consummate the transactions contemplated herein. The execution, delivery and
performance of this Agreement (and all other Transaction Documents required
to
effect the transactions contemplated herein) and the consummation of the
transactions contemplated herein have been duly authorized by all necessary
action on the part of Seller. This Agreement has been duly executed and
delivered by Seller and constitutes Seller’s valid and legally binding
obligation, enforceable against Seller in accordance with its terms and
conditions, except as the same may be limited by bankruptcy, insolvency,
reorganization or other laws affecting the enforcement of creditors’ rights
generally, now or hereafter in effect, and subject to the availability of
equitable remedies. Each Transaction Document to which Seller is a party, when
executed and delivered by Seller in accordance with the provisions hereof,
shall
be valid and legally binding upon Seller, as applicable, in accordance with
its
terms, subject only to applicable bankruptcy, reorganization, insolvency,
moratorium, and other rights affecting creditors’ rights generally from time to
time in effect and as to enforceability and general equitable principles.
4.3 Financial
Statements.
Attached to Schedule 4.3 are
true,
complete and correct copies of (i) the audited financial statements and notes
thereto of Seller (including balance sheets and related statements of income,
retained earnings and cash flows) at and for the fiscal years ended December
31,
2005 and 2006 and (ii) unaudited financial statements and notes thereto of
Seller (including
unaudited balance sheets and the related statements of income, retained earnings
and cash flows)
for the
fiscal year ended December 31, 2007. All such audited statements, including
the
footnotes thereto, were audited and reported upon by Xxxxxxxx Xxxxxxx &
Company, L.L.P., independent certified public accountants, in
an
unqualified auditors’ opinion without an explanatory paragraph.
Schedule 4.3 also sets forth Seller’s financial statements (including
unaudited balance sheets and the related statements of income, retained earnings
and cash flows) at and for the four months ended April 30, 2008 (the “Interim
Balance Sheet”). The foregoing financial statements are hereinafter collectively
referred to as the “Financial Statements”. The Financial Statements have been
prepared from the books and records of Seller, are true and correct, and fairly
present the financial position of Seller as at such dates and the results of
its
operations and the changes in its retained earnings and its financial positions
for the periods then ended in accordance with GAAP consistently applied
throughout the periods indicated. The Financial Statements do not contain any
material misstatements or omissions regarding the Business, Purchased Assets
or
condition (financial or otherwise) of Seller. Since the most recent fiscal
year
end, there have been no material changes in the accounting policies of Seller
except for any such changes required pursuant to GAAP. The Financial Statements
are not affected by transactions or accounts with affiliated companies, if
any,
other than as set forth in Schedule 4.3.
13
4.4 No
Material Adverse Change.
Except
as set forth in Schedule 4.4, since December 31, 2007 there has been no
material adverse change in the assets (including the Purchased Assets),
Properties, Liabilities, Business, condition (financial or otherwise) or
prospects of Seller, other than such as result from Seller’s continued losses
and deteriorating financial condition. Any change which has occurred reflects
only the ordinary and regular conduct of the Business or the normal use or
operation of the Purchased Assets, except for such changes as have been taken
to
preserve Seller’s cash at the expense of ongoing operations. Seller has no
Knowledge of any such change which is impending, nor has there been any damage,
destruction or loss affecting the Purchased Assets, Properties, Business or
financial condition of Seller, whether or not covered by insurance.
4.5 Tax
Matters.
(1)
Seller,
and any consolidated, combined, unitary or aggregate group for Tax purposes
of
which Seller is or has been a member, has timely filed with the appropriate
governmental agencies all Tax Returns required to be filed by it, all of which
have been prepared and completed in compliance with all Laws in all material
respects.
(2)
Except
as
set forth on Schedule 4.5, all Taxes due, owing and payable have been fully
paid
or duly provided for in the Financial Statements. No claim for Taxes due is
being contested by Seller.
(3)
No
written claim has ever been made by any governmental authority in a jurisdiction
where Seller does not file a Tax Return that it is or may be subject to taxation
by that jurisdiction.
(4)
None
of
the Purchased Assets is subject to any liens for Taxes, other than liens for
Taxes not yet due and payable.
(5)
Seller
has complied in all material respects with the provisions of the Code relating
to the withholding and payment of Taxes, including, without limitation, the
withholding and reporting requirements under Code sections 1441 through 1464,
3401 through 3406, and 6041 through 6049, as well as similar provisions under
any other Laws, and has, within the time and in the manner prescribed by Law,
withheld from employee wages and paid over to the proper governmental
authorities all amounts required.
(6)
Seller
has been properly treated as a partnership for United States federal income
tax
purposes from the time of its formation through the Closing Date.
4.6 Compliance
with Laws.
Except
as set forth in Schedule 4.6, to Seller’s Knowledge Seller has complied, in
all material respects, with all Laws relating to its Business or operations
or
to the Purchased Assets. Except as set forth and specifically identified in
Schedule 4.6, Seller has not received notice of any alleged material
violation of or claim under any such Laws, and there is no basis for any
material violation thereof which may occur in the future (either upon notice,
lapse of time, or both), and no investigation, charge, claim or other action
under any such Laws is pending or threatened.
14
4.7 Permits.
Except
as set forth in Schedule 4.7, no Permits or clearances are material to or
necessary for the conduct of the Business or the use and operation of the
Purchased Assets. Seller holds all Permits which are material to or necessary
for it to conduct its Business as heretofore conducted (“Material Permits”). A
true, correct and complete list of Seller’s Material Permits is set forth in
Schedule 4.7. All Material Permits are in full force and effect, no violations
are or have been recorded in respect of any Material Permit and no Proceeding
is
pending or to the Knowledge of Seller, threatened to revoke, terminate or limit
any Material Permit. Except as set forth and specifically identified in
Schedule 4.7, Seller is not in default, and has not received any notice of
any claim of default, with respect to any Material Permit or of any notice
of
any other claim or material Proceeding (or to the Knowledge of Seller,
threatened Proceeding) relating to any Material Permit. Except as set forth
in
Schedule 4.7, all Material Permits are assignable and transferable by
Seller to Buyer without the Consent of any Person. Schedule 4.7 sets forth
the
identification and/or registration numbers issued by any governmental authority,
including the FDA or state licensing agency, the Medicare or Medicaid programs
or any other plan or program that provides, or pays the cost of, medical care,
whether directly through insurance, or otherwise, which is funded directly,
in
whole or in part, by the United States government or similar program outside
the
United States, if any, for each applicable Material Permit.
4.8 No
Breach.
Except
as set forth and specifically identified in Schedule 4.8, the consummation
of the transactions herein contemplated including, without limitation, the
execution, delivery and performance of this Agreement and the Transaction
Documents, do not and will not (1) constitute a violation of or default
under (either immediately or upon notice, lapse of time or both), conflict
with
or result in a breach of (a) Seller’s organizational documents, (b) the
terms of any Assumed Contract or any Contract to which Seller is a party and
to
which the Purchased Assets are or may be bound, (c) any Judgment relating
to the Purchased Assets and binding upon Seller, or (d), to Seller’s Knowledge,
any Laws affecting the Purchased Assets or the Business; or (2) result in
the creation or imposition of any Encumbrance on any of the Purchased Assets
or
give to any Person any interest or right in any of the Purchased Assets or
the
Business; or (3) accelerate the maturity of or otherwise modify any
Liability or obligation of either Seller relating to the Purchased Assets or
the
Specified Liabilities; or (4) result in the breach of any of the terms and
conditions of, constitute a default under or otherwise cause any impairment
of,
any Assumed Contract or Permit which, if not cured, could have a Seller Material
Adverse Effect.
4.9 Consents
and Approvals.
Except
as set forth in Schedule 4.9, no material Consent, waiver, order or notice
is required in connection with the execution, delivery and performance by Seller
of this Agreement, the Transaction Documents or the consummation of the
transactions contemplated hereby, including, but not limited to, the assignment
of any and all of the Assumed Contracts.
15
4.10 Judgments
and Proceedings.
Except
as set forth in Schedule 4.10, there is no outstanding Judgment against or
affecting the Purchased Assets or the Business. Except as set forth in
Schedule 4.10, there is no Proceeding pending, or to the best of Seller’s,
Knowledge, threatened, against or affecting any of Seller’s Properties, assets,
Business, operations, and the Seller has no Knowledge of and has no reasonable
grounds to know of any basis for any such Proceeding. True and correct copies
of
all complaints, pleadings, petitions, notices, motions and other papers filed
in
connection with any Proceedings listed in Schedule 4.10 have been delivered
to Buyer. Except as set forth and specifically identified in Schedule 4.10,
there are no Proceedings pending or, to the best of Seller’s Knowledge,
threatened, or any contingent liability, which would give rise to any right
of
indemnification on the part of any officer, director, employee or agent of
Seller or heirs, executors or administrators thereof against Seller or any
successor. Except as set forth and specifically identified in
Schedule 4.10, no material breach of contract, tort, negligence,
infringement, product liability, discrimination, wrongful discharge or other
claim (whether arising from Seller’s business operations or otherwise) has been
asserted or, to the best of Seller’s Knowledge, is capable of assertion, by any
Person against Seller, nor has there been any occurrence which could give rise
to such a claim, and no breach of contract claim has been asserted by Seller
against any Person, nor has there been any occurrence which could give rise
to
such claim, with regard to the Assumed Contracts.
4.11 Contracts.
Schedule 4.11 sets forth a true and correct list of all Assumed Contracts
and any other Contract to which any Purchased Asset is bound or subject.
True and correct copies of all such written Contracts have been delivered to
Buyer. All of the Assumed Contracts are valid, subsisting, in full force and
effect and binding on the parties thereto in accordance with their terms; Seller
is not in default under any of them nor to the Knowledge of Seller is any other
party to any such Contract in default thereunder, nor is there any condition
or
basis for any claim of a default by any party thereto or event which, with
notice, lapse of time or both, would constitute a default thereunder. Seller
has
paid in full or accrued all amounts due thereunder for periods on or prior
to
the date hereof (whether or not currently payable) and has satisfied in full
or
provided in full for all of its Liabilities and obligations thereunder for
periods on or prior to the date hereof. Except as disclosed in
Schedule 4.11, all rights of Seller under the Assumed Contracts extending
beyond the Closing Date are assignable to Buyer and upon assignment shall
continue unimpaired and unchanged in Buyer on and after the Closing Date without
(a) the Consent of any Person or (b) the payment of any penalty, the
incurrence of any additional obligation or the change of any term.
4.12 Real
Property.
(1)
Seller
does not own all or any portion of any Real Property.
(2)
Schedule
4.12 sets forth a true and correct list of (a) all Contracts under which
Seller is lessor, lessee, sublessor or sublessee of any Real Property;
(b) all options held or given by Seller and all contractual obligations on
the part of Seller to sell, purchase or acquire any interest in Real Property;
and (c) all other Contracts affecting or relating to Seller’s leased Real
Property.
(3)
To
the
Knowledge of Seller, there has not been filed by or against any landlord any
bankruptcy or insolvency petition or any assignment for the benefit of
creditors, nor is any landlord in default under any mortgage or underlying
lease
covering any Real Property, nor are there any current foreclosure Proceedings
against any landlord or leased Real Property.
16
(4)
Except
as
set forth in Schedule 4.12, to Seller’s Knowledge, none of the Real Property
leased by Seller or the use, occupancy, operation or maintenance thereof, is
in
material violation of any restrictive covenants, Laws, or any building, zoning,
environmental, health, fire, safety or other ordinances, codes or regulations.
To Seller’s Knowledge, there have been no hazardous materials treated, stored or
disposed of, or otherwise deposited, in or on the Real Property leased by Seller
(including, but not limited to, any surface waters or subsurface waters on
or
flowing through the Real Property leased by Seller.
4.13 Books
of Account and Reports.
Seller’s books of account and other financial books and records are true,
correct and complete and accurately reflect all of its items of income and
expense, and all of its assets, Liabilities and accruals are and have been
prepared and maintained in accordance with applicable Laws (including any
record-keeping, inventory and other requirements and regulations of the FDA,
the
Federal Drug Enforcement Agency, any federal or state pharmacy board and other
governmental authority). Seller has filed all reports required by all Laws
to be
filed, and it has duly paid or accrued on its books of account all applicable
duties and charges due or assessed against it pursuant to such reports.
4.14 Tangible
Property.
Schedule 4.14 sets forth a list and summary description of all interests owned,
leased or subleased (as lessor or lessee) or claimed by Seller (including,
without limitation, options) in or to Tangible Property having an individual
value equal to or greater than $5,000. Except as set forth on Schedule 4.14,
all
Contracts pursuant to which Seller may hold or use any interest owned or claimed
by Seller (including, without limitation, options) in or to Tangible Property
are in full force and effect, Seller is not in default thereunder and no
condition exists which, with notice, lapse of time or both, would constitute
a
default. The Purchased Assets which comprise Tangible Property are in good
operating condition and repair, except for Seller’s server referred to in
Section 9.1(9), which currently is not used in Seller’s business and which
Seller does not intend to repair. Seller has not received notice that any such
Tangible Property is in violation of any material Laws.
4.15 Intangibles.
(1)
Schedule
4.15 contains an accurate and complete list and description of all Seller
Intangibles, and, in the case of Software, a product description including
a
reasonably detailed feature set of the products as it is currently being
supported for any customer or other Person, a listing of all modules that are
a
part of such Software, including a reasonable description of the modules’
function and a listing of each file that forms a part of the relevant module,
the language in which it is written, and the type of hardware and software
platform(s) on which it runs including a detailed description of each
third-party software needed to cause the Software to perform all of its intended
functions. Except as set forth on Schedule 4.15, no Intangibles other than
the
Seller Intangibles are necessary for or used in the operation of the
Business.
17
(2)
Except
as
set forth on Schedule 4.15, Seller has all right, title and interest in and
to,
including good and indefeasible title and the full right to use, all Seller
Intangibles, free and clear of any Encumbrance other than a Permitted
Encumbrance. Schedule 4.15 sets forth all third party Software and Intangibles
used in connection with, or necessary to market, license, sell, or modify the
Seller Intangibles, indicating whether or not such third party Software, or
any
portion thereof, is or has been embedded in any Seller Software. Except as
set
forth on Schedule 4.15, no rights of any other third party are necessary to
market, license, sell, offer for sale, modify, update, use and/or create
derivative works of the Seller Intangibles. Except as set forth on Schedule
4.15
or as provided in the Assumed Contracts, Seller is not required or obligated
to
provide any modifications, updates or upgrades with respect to any of its
Software to any customer or other Person.
(3)
Except
as
set forth on Schedule 4.15, all of the Seller Intangibles were created as a
work
for hire (as defined under U.S. copyright law) by regular full time employees
of
Seller or one of its Affiliates. Except as set forth on Schedule 4.15, to the
extent that any author or developer of the Seller Intangibles was not a regular
full-time employee of Seller at the time such person contributed to any Seller
Intangibles, such author or developer has irrevocably assigned to Seller in
writing all Intellectual Property Rights and other proprietary rights in such
person’s work with respect to such Seller Intangibles.
(4)
With
respect to the Software required to be listed on Schedule 4.15, except as set
forth on Schedule 4.15, (i) Seller maintains machine-readable
master-reproducible copies, source code listings, technical documentation and
user manuals for the most current releases or versions thereof and for all
earlier releases or versions thereof currently being, or which by contract
for
the benefit of any customer is to be supported by it; (ii) in each case, the
machine-readable copy substantially conforms to the corresponding source code
listing; (iii) it is written in the language set forth on Schedule 4.15 for
use
on the hardware set forth on Schedule 4.15 or with standard operating systems;
and (iv) in each case, it operates in accordance with the user manual therefore
without material operating defects or known, reproducible errors.
(5)
Except
as
set forth on Schedule 4.15, with respect to any Seller Intangible, no Software
that is free software, open source, public source, shareware, freeware or
similar Software (“OSS”), or any enhancement, modification, improvement or
derivative thereof, including any Software licensed pursuant to any version
of
any general or other public license, including any GNU general public license
or
the limited or lesser general public license, or any other license for OSS
(“Public License”), is used in, incorporated into, integrated with, bundled with
or used in conjunction with any Software or any Seller Intangible. Seller has
complied and is in compliance with the terms of each license governing the
use
of each OSS disclosed or required to be disclosed on Schedule 4.15 and Seller
has delivered or made available accurate and complete copies of each such
license to Buyer.
(6)
Other
than as set forth on Schedule 4.15, to Seller’s Knowledge, none of the Seller
Intangibles or their respective uses, including the preparation, manufacture,
distribution, marketing, selling or licensing thereof, has violated or infringed
upon, is violating or infringing upon, or by conducting the Business as
currently conducted by Seller, will violate or infringe upon, any Software,
technology, copyright, trade secret or other Intangible or any Intellectual
Property Right or other proprietary right of any Person. Other than as set
forth
on Schedule 4.15, none of the Seller Intangibles is subject to any Judgment.
No
claim or demand has been made on Seller and to the Seller’s Knowledge, no
Proceeding is pending or threatened which challenges or challenged the legality,
validity, enforceability, use or exclusive ownership by Seller of any of the
Seller Intangibles. To the Knowledge of Seller, no Person is violating or
infringing upon, or has violated or infringed upon at any time, any of the
Seller Intangibles.
18
(7)
Seller
has used commercially reasonable efforts to maintain all trade secrets and
other
confidential information with respect to the Seller Intangibles. Except as
set
forth on Schedule 4.15, Seller has not disclosed or delivered to any escrow
agent or to any other Person, or permitted the disclosure to any escrow agent
or
to any other Person of, and has taken all reasonable precautions to prevent
the
disclosure of the source code and the object code (or any aspect or portion
thereof) for or relating to any past, present or future product, trade secret,
program, system, Software, or Seller Intangible
(8)
Schedule
4.15 identifies any of the Seller Intangibles not titled in Seller. Except
as
set forth on Schedule 4.15, any material license, sublicense or other material
Contract covering or relating to any Seller Intangible is legal, valid, binding,
enforceable and in full force and effect, and upon consummation of the
transactions contemplated hereby, will continue to be legal, valid, binding,
enforceable and in full force and effect on terms identical to those in effect
immediately prior to the consummation of the transactions contemplated hereby.
Except as set forth on Schedule 4.15, Seller is not in breach of or default
under any material license, sublicense or other material Contract covering
or
relating to any Seller Intangible or has performed any act or omitted to perform
any act which, with notice or lapse of time or both, will become or result
in a
material violation, breach or default thereunder. No material Proceeding is
pending, or to Seller’s Knowledge, is being or has been threatened nor has any
claim or demand been made, which challenges the legality, validity,
enforceability or ownership of any material license, sublicense or other
material Contract covering or relating to any Seller Intangible.
(9)
Except
as
set forth on Schedule 4.15, none of the Software or other Intangibles listed
or
required to be listed on Schedule 4.15 is owned by or registered in the name
of
any current or former owner, parent, affiliate, shareholder (whether direct
or
indirect), partner, director, executive, officer, employee, salesman, agent,
customer, representative or contractor of Seller nor does any such Person have
any interest therein or right thereto, including the right to royalty payments.
(10)
To
Seller’s Knowledge based on its use thereof in the ordinary course of conducting
its business, except with respect to demonstration or trial copies, no portion
of any Seller Intangibles contains any “back door,” “time bomb,” “Trojan horse,”
“worm,” “drop dead device,” “virus” or other software routines or hardware
components designed to permit unauthorized access or to disable or erase
software, hardware, or data without the consent of the user.
(11)
Set
forth
on Schedule 4.15 are all Internet domain names related to the Business (“Domain
Names”) of Seller. Seller is the registrant of all Domain Names, and all
registrations of Domain Names are in good standing as of the date hereof. Except
as set forth on Schedule 4.15, no action has been taken or is pending to
challenge the rights of Seller to use or to suspend, cancel or disable any
Domain Name, registration therefor or the right of Seller to use a Domain Name.
Except as set forth on Schedule 4.15, Seller owns all right, title and interest
in and to, or holds all rights necessary to use on the Internet and otherwise
as
a trademark and trade name, the Domain Names.
19
(12)
Except
as
set forth on Schedule 4.15, and assuming due compliance by all Persons other
than the Seller with applicable regulatory requirements, to Seller’s Knowledge
there is no governmental prohibition or restriction on the use of any of the
Seller Intangibles in the United States.
(13)
Except
as
disclosed on Schedule 4.15, Seller is the sole owner of, and has good and
marketable title to, and all right, title and interest in and to all databases
related to the Business. Except as specified on Schedule 4.15, no Person other
than Seller has any right or interest of any kind or nature in or to such
databases. To the Knowledge of Seller, no person (i) is violating or infringing
upon, or has violated or infringed upon at any time, any right of Seller in
or
to such databases; or (ii) is breaching or has breached at any time any duty
or
obligation owed to Seller in respect of such databases. Except as set forth
on
Schedule 4.15, all licenses referred to on Schedule 4.15 are in full force
and
effect and neither Seller nor the other party thereto is in default of its
obligations thereunder. To Seller’s Knowledge, the use of any such database or
the information contained therein in the Business (i) has not violated or
infringed upon, and is not currently violating or infringing upon, the rights
of
any Person; or (ii) does not breach any duty or obligation owed to any Person;
or (iii) does not violate the privacy or any Law relating to the privacy of
any
Person.
(14)
Except
as
set forth on Schedule 4.15, to the Knowledge of Seller, neither Seller nor
any
Affiliate has exported or re-exported, directly or indirectly (including via
remote access) any part of any Seller Intangible or Software or any other
commodities, software or technical data to any country for which a license
is
required under applicable Law relating to the control of imports and exports
of
commodities and technical data, use and remote use of Software and related
property, and related matters, including the Export Administration Regulations
administered by the U.S. Department of Commerce, the International Traffic
in
Arms Regulations administered by the U.S. Department of State, and the economic
sanctions programs and trade embargoes administered by the Office of Foreign
Assets Control of the U.S. Department of the Treasury, without first obtaining
all applicable licenses, and Seller is, and during the five (5) years preceding
the date of this Agreement have been, in compliance with all such
Laws.
(15)
Seller
in
connection with its operations, activity, conduct, and business on the World
Wide Web (“Web”) only collects on its web sites (“Seller Web Sites”) the type of
customer information listed on Schedule 4.15. Such collected information is
used
by Seller in connection with the Business.
(16)
To
Seller’s Knowledge, no linking, hyperlinking, deep-linking, framing, or other
means or method by which a Seller Web Site visitor may move or transfer directly
from any Seller Web Site to another Web site or view or access another Web
site
from any Seller Web Site, violates, interferes with, infringes upon, or breaches
any legal or Intellectual Property Right of any Person.
20
4.16 Title.
Except
as set forth on Schedule 4.16, Seller owns outright and has good, valid and
marketable title to all of the Purchased Assets, free and clear of all
Encumbrances, other than any Permitted Encumbrances. There are no outstanding
options or commitments to which Seller is a party which relate to the Purchased
Assets or the sale by any of them of the Purchased Assets. At Closing, Buyer
shall acquire all assets used by Seller in the Business, other than the Excluded
Assets. Within the past ten (10) years, Seller has not done business under
or
been known by any name other than its present corporate name (other than CAD
Sciences), or done business at any address other than the addresses set forth
in
Schedule 4.16.
4.17 Indebtedness.
All
Specified Liabilities as of the Closing Date are set forth on Schedule 4.17.
4.18 Undisclosed
Liabilities.
As of
the Closing Date, Seller has no material Liabilities in respect of its Business,
other than (1) Liabilities fully and adequately reflected or reserved for on
the
Financial Statements, (2) Liabilities that have arisen or been incurred since
December 31, 2007 in the ordinary course of business consistent with past
practices or (3) Liabilities to Seller’s agents and Employees that will arise as
of the consummation of the transaction contemplated hereby and which will be
satisfied out of the proceeds hereof. Except for liabilities arising out of
the
arrangements described in the preceding clause (3), Seller has no Knowledge
of
any circumstances, bases (either with notice, lapse of time or both),
conditions, events or arrangements which may hereafter give rise to any
Liabilities of Seller or any successor to the Business of Seller except in
the
ordinary course of business consistent with past practices.
4.19 Suppliers
and Customers.
Set
forth
in Schedule 4.19 are all of the customers of Seller and the sales to such
customers for 2007. Set forth on Schedule 4.19 are those suppliers from which
Seller during 2007 purchased software or hardware material to the operation
of
its business. To
Seller’s Knowledge, (1) no supplier, customer or licensee of Seller intends to
cancel or materially reduce its ongoing commercial relationship with the
businesses of Seller or (2) the acquisition of the Purchased Assets by Buyer
will not adversely affect the relationship with any such customer or
supplier.
4.20 Potential
Conflicts of Interest.
No
officer, director or employee of Seller has any cause of action or other claim
whatsoever against, or owes any amount to, Seller, except for amounts owed
by
Seller for loans and other amounts made to Seller which comprise Retained
Liabilities. Such officers, directors and employees are only permitted to look
to Seller for the satisfaction of such loans.
4.21 Product
Warranty.
Each
product manufactured, sold, leased, or delivered by Seller has been in
conformity with all applicable contractual commitments and all express and
implied warranties, and Seller has no Liability (and there is no basis for
any
present or future Proceeding against either of them giving rise to any
Liability) for replacement or repair thereof or other damages in connection
therewith, subject only to the reserve for product warranty claims set forth
on
the face of the Interim Balance Sheet as adjusted for the passage of time
through the Closing Date in accordance with the past custom and practice of
Seller. Except as set forth in the Assumed Contracts, no product manufactured,
sold, leased, or delivered by Seller is subject to any guaranty, warranty,
or
other indemnity beyond the applicable standard terms and conditions of sale
or
lease.
21
4.22 Inventory.
The
Inventory of Seller is merchantable and fit for the purpose for which it was
procured or manufactured, and none of the Inventory of Seller is obsolete,
damaged, or defective, subject only to the reserve for inventory writedown
set
forth on the face of the Interim Balance Sheet as adjusted for the passage
of
time through the Closing Date in accordance with the past custom and practice
of
Seller. Schedule 4.22 contains
an accurate and complete list of all Inventory as of April 30,
2008,
and the cost to Seller of each item listed thereon. Except as set forth in
Schedule 4.22, all Inventory reflected on the Financial Statements was and
all
of Seller’s Inventory as of the Closing Date has been reflected on Seller’s
books and records in accordance with GAAP consistently applied, stated on an
aggregate basis, at cost. Except as set forth in Schedule 4.22, the Inventory
of
Seller conforms to customary trade standards for marketable goods.
4.23 FDA
Qualification and Approvals.
(1)
To
the
Knowledge of Seller, Seller is in compliance in all material respects with
the
provisions of all laws, rules and regulations applicable to Seller and its
products, including the FDCA and all applicable state and foreign Laws and
regulations comparable to the FDCA, the rules and regulations promulgated
thereunder and all rules and regulations promulgated by the FDA and all
comparable and applicable state and foreign regulatory authorities, including
but not limited to those Laws and regulations relating to investigational use,
premarket clearance, good manufacturing practices, labeling, advertising, record
keeping, medical device reporting, and security. Seller has obtained all
material Consents, orders or Permits of any court or the FDA and all comparable
state and foreign regulatory authorities which are necessary or required for
it
to conduct its Business as now conducted. Seller has had no material
liabilities, debts, obligations or claims asserted against it, whether accrued,
absolute, contingent or otherwise, and whether due or to become due, on account
of such regulatory matters. No governmental authority has initiated legal action
with respect to the manufacturing of Seller’s products, such as seizures or
required recalls, and Seller is in compliance in all material respects with
applicable good manufacturing practice regulations.
(2)
All
applications, submissions, information, claims and statistics and other data
and
conclusions derived therefrom, utilized as the basis for or submitted in
connection with any and all requests for such Consents, orders or Permits are
accurate, complete, correct and true in all material respects as of the date
of
submission and any necessary or required updates, changes, corrections or
modification to such applications, submissions, information and data have been
submitted to the appropriate regulatory body.
(3)
All
experiments, human or otherwise, performed in connection with or as the basis
for any regulatory approval required for Seller’s products have been performed
in accordance with appropriate research and study design, and all required
protocols and consents and any conclusions derived therefrom are scientifically
supported. The claims approved by the FDA for Seller’s products are valid and
supported by proper research design, testing, analysis and
disclosure.
22
(4)
Except
as
set forth on Schedule 4.23, no product of Seller has been recalled, withdrawn,
suspended or discontinued by Seller. No Proceedings are pending or to Seller’s
Knowledge threatened, against Seller seeking the recall, withdrawal, suspension
or seizure of any product of Seller. Seller has not received notice that the
FDA
or any state or foreign regulatory authority has commenced or threatened to
initiate any action to withdraw its approval or to request the recall of any
product of Seller, or has commenced or threatened to initiate any action to
enjoin production at any facility of Seller.
(5)
Seller
has been operating in compliance, in all material respects, with all reporting
and regulatory requirements and Laws imposed upon it, including reporting to
FDA
and other regulatory agencies, to include product deviations, device
malfunctions and/or device related serious injuries or deaths and reporting
to
FDA of corrections, recalls or removals, when and as required under the
FDCA.
(6)
Neither
Seller, nor any officer, employee or agent of Seller has made any untrue
statement of a material fact or fraudulent statement to the FDA or any state
or
foreign regulatory authority or failed to disclose a fact required to be
disclosed to the FDA or any state or foreign regulatory authority, or committed
any act, made any statement or failed to make any statement that, at the time
such disclosure was made, could reasonably be expected to provide a basis for
the FDA or any other regulatory authority to invoke with respect to Seller
its
policy respecting “Fraud, Untrue Statements of Material Facts, Bribery, and
Illegal Gratuities,” set forth in 56 Fed. Reg. 46191 (Sept. 10, 1991) or any
similar policy.
4.24 Related
Party Transactions.
Except
as described on Schedule 4.24 and except for any employment or consulting
Contracts listed on Schedule 4.11, there are currently no Real Property leases,
personal property leases, guarantees, Contracts, transactions, understandings
or
other arrangements of any nature between or among Seller and any current or
former member, owner, shareholder, partner, director, officer or controlling
Person of Seller (or any of their respective predecessors) or any other Person
affiliated with Seller (or its predecessors). Seller has borrowed substantial
sums from its members, officers, directors and certain employees which comprise
Retained Liabilities.
4.25 No
Broker.
Except
as set forth in Schedule 4.25, no broker, finder, agent or similar intermediary
has acted for or on behalf of Seller in connection with this Agreement or the
transactions contemplated hereby, and no broker, finder, agent or similar
intermediary is entitled to any broker’s fee, finder’s fee, or similar fee or
commission in connection therewith based on any agreement, arrangement or
understanding with Seller or any action taken by Seller. Any item disclosed
in
Schedule 4.25 will be paid by Seller.
4.26 Investment
Matters.
The
Shares to be issued hereunder are being acquired for Seller’s own account and
not on behalf of any other Person, and all such Shares are being acquired for
investment purposes only and not with a view to, or for sale in connection
with,
any resale or distribution of such Shares. Seller has received or examined
Buyer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2007,
Buyer’s
Amended Annual Reports on Form 10-K/A for the fiscal year ended December 31,
2007, Buyer’s
Quarterly Report on Form 10-Q for the quarter ended March 31, 2008, all
current reports on Form 8-K filed since December 31, 2007 and Buyer’s May 15,
2008 Proxy Statement. Seller has had the opportunity to ask questions and
receive answers from Buyer concerning Buyer, and have been furnished with all
other information about Buyer which it has requested. Seller believes that
it
has been fully apprised of all facts and circumstances necessary to permit
it to
make an informed decision about acquiring the Shares, that it has sufficient
Knowledge and experience in business and financial matters that it is capable
of
evaluating the merits and risks of an investment in the Shares, and that it
has
the capacity to protect its own interests in connection with the transactions
contemplated hereby. Seller has been advised by Buyer and understand that,
(1) the Shares to be issued hereunder will not be registered under any
federal or state securities laws, (2) such Shares must be held unless and
until they are subsequently registered or an exemption from registration becomes
available, (3) the certificates representing such shares shall bear
appropriate restrictive legends, and (4) Buyer shall have the right to
direct the transfer agent of its common stock to place a stop transfer order
against such certificates.
23
4.27 Full
Disclosure.
All
Documents delivered by or on behalf of Seller in connection with this Agreement
and the transactions contemplated hereby are true and complete and authentic.
5. Representations
and Warranties of Buyer.
Knowing
that Seller is relying thereon, Buyer represents, warrants and covenants to
Seller as of the date hereof and as of the Closing as set forth in this Section
5 as follows:
5.1 Due
Incorporation and Qualification.
Each of
Buyer and each of its Subsidiaries is an entity duly incorporated or otherwise
organized, validly existing and in good standing under the laws of the
jurisdiction of its incorporation. Each of Buyer and its Subsidiaries has the
corporate or other similar applicable power and authority necessary to own,
lease and operate their respective assets and business, to carry on their
respective businesses as and where such businesses are now conducted, except
where such failure to have such power and authority would not have a Buyer
Material Adverse Effect. Buyer has full power and authority to execute, deliver
and enter into and perform this Agreement and each of the other Transaction
Documents to which it is a party and to consummate the transactions contemplated
hereby and thereby upon the terms and conditions herein and therein provided.
Each of Buyer and its Subsidiaries is duly qualified as a foreign corporation
or
other entity in good standing under the Laws of each jurisdiction in which
the
nature of their respective business or the location of any of their respective
assets requires such licensing or qualification, except where the failure to
be
so qualified or licensed would not have a Buyer Material Adverse Effect.
5.2 Authority
to Execute and Perform Agreement.
The
execution and delivery by Buyer of this Agreement and each of the other
Transaction Documents to which it is a party and the consummation of the
transactions contemplated hereby and thereby have been duly and validly
authorized by all necessary corporate action on the part of Buyer. This
Agreement constitutes a valid and legally binding agreement of Buyer,
enforceable against it in accordance with its terms, subject only to applicable
bankruptcy, reorganization, insolvency, moratorium, and other rights affecting
creditors’ rights generally from time to time in effect and as to enforceability
and general equitable principles. Each Transaction Document to which Buyer
is a
party, when executed and delivered by Buyer in accordance with the provisions
hereof, shall be valid and legally binding upon Buyer in accordance with its
terms, subject only to applicable bankruptcy, reorganization, insolvency,
moratorium, and other rights affecting creditors’ rights generally from time to
time in effect and as to enforceability and general equitable
principles.
24
5.3 No
Breach.
The
consummation of the transactions herein contemplated including, without
limitation, the execution, delivery and performance by Buyer of this Agreement
and each of the other Transaction Documents to which it is a party do not and
will not constitute a violation of or default under (either immediately or
upon
notice, lapse of time or both) or result in a breach of (a) Buyer's certificate
of incorporation, bylaws or other organizational documents, (b) the terms of
any
Contract to which Buyer or any of its Subsidiaries or any of their respective
assets are bound, (c) any Judgment binding upon Buyer or any of its
Subsidiaries, (d) any Permit; or (e) any Law (including federal and state
securities laws) applicable to Buyer or any of its Subsidiaries or any of their
respective Purchased Assets, except, in the cases of clause (b), (c), (d) or
(e), any such violation, default or breach that would not have a Buyer Material
Adverse Effect.
5.4 No
Broker.
No
broker, finder, agent or similar intermediary has acted for or on behalf of
Buyer in connection with this Agreement or the transactions contemplated hereby,
and no broker, finder, agent or similar intermediary is entitled to any broker’s
fee, finder’s fee, or similar fee or commission for which either Seller will be
liable in connection therewith based on any agreement, arrangement or
understanding with Buyer or any action taken by Buyer.
5.5 Capitalization.
The
issue and sale of the Shares will not, immediately or with the passage of time,
obligate Buyer to issue shares of Buyer's Stock or other securities to any
Person (other than Seller) and will not result in a right of any holder of
Buyer
securities to adjust the exercise, conversion, exchange or reset price under
such securities. To the knowledge of Buyer, except as set forth in the SEC
Reports (as hereinafter defined), no Person or group of related Persons
beneficially owns (as determined pursuant to Rule 13d-3 under the Exchange
Act),
or has the right to acquire, by agreement with or by obligation binding upon
Buyer, beneficial ownership of in excess of 5% of the outstanding Buyer's Stock,
ignoring for such purposes any limitation on the number of shares of Buyer's
Stock that may be owned at any single time.
5.6 Tax
Matters.
(i)
Buyer and its Subsidiaries have timely filed all Tax Returns (other than
franchise Tax Returns) that are required to be filed before the Closing Date,
(ii) the information provided on such Tax Returns is complete and accurate
in
all material respects and (iii) all Taxes shown to be due on such Tax Returns
have been paid in full.
5.7 Issuance
of Buyer’s Stock.
The
shares of Buyer’s Stock being issued in connection with this Agreement are duly
and validly authorized and issued, fully paid and nonassessable, free and clear
of all Encumbrances (other than those restrictions pursuant to the Securities
Act of 1933, as amended (the “Securities Act”)) and are not subject to
preemptive or similar rights. Assuming the information provided by Seller set
forth in Section 4.26 is accurate and correct, no registration under the
Securities Act is required for the offer and sale of the Shares to Seller under
this Agreement.
25
5.8 Filings,
Consents and Approvals.
Buyer
is not required to obtain any Consent or waiver, give any notice to, or make
any
filing or registration with, any court or other federal, state, local or other
governmental authority, The Nasdaq Capital Market or other Person in connection
with the execution, delivery and performance by Buyer of this Agreement and
the
other Transaction Documents to which it is a party.
5.9 Regulatory
Compliance.
Since
December 31, 2005, Buyer has duly and timely filed all reports, schedules,
forms, statements and other documents required to be filed by it with the
Securities and Exchange Commission (the “SEC”) pursuant to the reporting
requirements of the Exchange Act, including material filed pursuant to Section
13(a) or 15(d) of the Exchange Act (the foregoing materials being collectively
referred to herein as the “SEC Reports”). As of their respective dates (unless
amended, and if amended, as of the amended date), the SEC Reports complied
in
all material respects with the requirements of the Exchange Act and the rules
and regulations of the SEC promulgated thereunder and other federal, state
and
local laws, rules and regulations applicable to such documents and did not
contain any untrue statement of a material fact or omit to state any material
fact required to be stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they were made, not
misleading. To the knowledge of Buyer, except as set forth in the SEC Reports,
since December 31, 2005, Buyer has not entered into any agreement or
arrangement, taken any action or incurred any Liability, nor has any event
occurred, which, pursuant to applicable Laws, would require Buyer to disclose
such agreement, arrangement, action, Liability or event in its annual report
on
Form 10-K for Buyer's fiscal year ended December 31, 2007. The financial
statements of Buyer included in the SEC Reports comply in all material respects
with applicable accounting requirements and the rules and regulations of the
SEC
with respect thereto as in effect at the time of filing. Such financial
statements have been prepared in accordance with GAAP, except as may be
otherwise specified in such financial statements or the notes thereto, or,
in
the case of unaudited financial statements, as permitted by Rule 10-01 of
Regulation S-X promulgated under the Securities Act and the Exchange Act, and
fairly present in all material respects the financial position of Buyer and
its
consolidated Subsidiaries as of and for the dates thereof and the results of
operations and cash flows for the periods then ended, subject, in the case
of
unaudited statements, to normal, immaterial, year-end audit
adjustments.
5.10 No
Buyer Material Adverse Change.
Since
December 31, 2007 there has not occurred a change in the business, properties,
assets or financial condition of Buyer or any of its Subsidiaries that,
individually or in the aggregate, has had a Buyer Material Adverse
Effect.
5.11 Compliance
with Laws.
Since
December 31, 2005, the business of Buyer and its Subsidiaries has been conducted
in compliance with all applicable Laws, except for any failure to be so
conducted that would not have a Buyer Material Adverse Effect.
6. Deliveries
by Seller.
At the
Closing, Seller shall deliver, or cause to be delivered, to Buyer, the
following, which shall be in form and substance acceptable to Buyer and Buyer’s
counsel:
6.1 Documents
and instruments of transfer for the Purchased Assets including, without
limitation, bills of sale for all Tangible Property, assignments of all
Intangibles (including all Intellectual Property Rights appurtenant thereto)
and
assignments of all assignable licenses and Permits relating to the Purchased
Assets or the use, occupancy or operation thereof including, but not limited
to,
Documents substantially in the form of Exhibit
B
(Xxxx of
Sale), Exhibit
C
(Master Trademark Assignment Agreement), Exhibit
D
(Master
Patent Assignment Agreement), Exhibit
E
(510(k)
Clearances Assignment Agreement) and Exhibit
F
(Assumption and Assignment Agreement);
26
6.2 Copies
of
the minutes of the meetings of the managers and members of Seller authorizing
the execution and performance of this Agreement and the amendment of Seller’s
certificate of formation to change its name, certified by Seller’s Secretary;
6.3 The
Purchased Assets, copies or originals of including files, papers, books and
records, licenses, Permits, applications, correspondence, and other Documents
included in the Purchased Assets being delivered hereunder;
6.4 Termination
statements and any other termination documents terminating all Encumbrances
in
and to the Purchased Assets;
6.5 A
certificate, dated no earlier than five (5) days prior to the Closing Date,
that
Seller is in good standing in its jurisdiction of formation;
6.6 Certificate
of incumbency and specimen signatures of all signatory officers of Seller,
certified by Seller’s Secretary;
6.7 Permits
and Consents from any person required for consummation of the Closing in form
and substance satisfactory to Buyer including, without limitation, all
governmental and administrative Consents and approvals and Consents required
under any Contract;
6.8 The
Escrow Agreement duly executed by Seller;
6.9 A
certificate of an officer of Seller, dated as of the Closing Date and signed
by
an executive officer of Seller, expressly certifying that the conditions set
forth in Sections 9.1(1), 9.1(2) and 9.1(3) have been met;
6.10 The
Consents and Approvals listed on Schedule 9.1(8).
6.11 All
such
further Documents and Contracts which may be reasonably requested by Buyer
or
its counsel, in order to more effectively transfer title to the Purchased Assets
to Buyer, or to effectuate and carry out any provision of this Agreement and
the
trans-action provided herein.
7. Deliveries
by Buyer.
Concurrently herewith at the Closing, Buyer is delivering to Seller the
following, which shall be in form and substance acceptable to Seller and
Seller’s counsel:
27
7.1 The
Purchase Price (including
delivery of an irrevocable instruction letter to Buyer's transfer agent to
issue
the Shares);
7.2 Assignment
and Assumption Agreement pursuant to which Buyer assumes the Specified
Liabilities;
7.3 A
certificate, dated no earlier than five (5) days prior to the Closing Date,
that
Buyer is in good standing in its jurisdiction of formation;
7.4 the
Escrow Agreement duly executed by Buyer;
7.5 A
certificate of an officer of Buyer, dated as of the Closing Date and signed
by
an executive officer of Buyer, expressly certifying that the conditions set
forth in Sections 9.2(1) and 9.2(2) have been met; and
7.6 All
such
further Documents and Contracts which may be reasonably requested by Seller
or
its counsel, in order to more effectively transfer title to the Purchased Assets
to Buyer, or to effectuate and carry out any provision of this Agreement and
the
transaction provided herein.
8. Covenants
and Agreements
8.1 Certain
Pre-Closing Covenants.
During
the period between the date of this Agreement and the earlier of (i) the Closing
and (ii) termination of this Agreement pursuant to Section 13:
(1)
General.
Each of
the parties will use its commercially reasonable efforts to take all action
and
to do all things necessary, proper or advisable in order to consummate and
make
effective the transactions contemplated by this Agreement (including the
satisfaction, but not waiver, of the closing conditions set forth in Sections
9.1 or 9.2 as the case may be).
(2)
Notices
and Consents.
Seller
will give any notices to third parties and will use their commercially
reasonable efforts to obtain any third party Consents listed on Schedule 9.1(8)
required under any legal or contractual obligation necessary to complete the
transactions contemplated hereby. Each of the parties will give any notices
to,
make any filings with, and use such party’s commercially reasonable efforts to
obtain any Consents or Approvals of any governmental authority and other third
parties necessary to consummate the transactions contemplated hereby and the
Transaction Documents.
(3)
Full
Access.
Seller
will provide representatives of Buyer with full access to, or copies of, all
of
the Assumed Contracts which are comprised of customer contracts for purposes
of
conducting the due diligence investigation.
(4)
Operation
of Business.
Seller
covenants and agrees, subject to the limitations of Seller’s resources, to
conduct the Business only in the ordinary course and in a manner consistent
with
its immediate past practice after giving effect to its recent reduction in
personnel and other cost saving measures, and in compliance with applicable
Laws, and to use its commercially reasonable efforts to preserve the present
goodwill of Seller and its relationships with customers, suppliers and other
Persons related to the Business. In addition to the foregoing, except as
specifically permitted by any other provisions in this Agreement, Seller shall
not, between the date hereof and the Closing Date, directly or indirectly,
take
any of the following actions without the prior written consent of
Buyer:
28
(a) amend
its
certificate of formation, operating agreement or other formation documents
or
alter through merger, liquidation, reorganization, restructuring or in any
other
fashion the structure or ownership of Seller;
(b) acquire
or agree to acquire by merging or consolidating with, or by purchasing a
substantial portion of the stock or assets of, or by any other manner, any
business or corporation, partnership, joint venture, association or other
business organization or division thereof; or any assets that are material,
individually or in the aggregate, to Seller, except purchases in the ordinary
course of business consistent with past practice;
(c) sell,
lease, license, mortgage or otherwise encumber or subject to any Encumbrance
or
otherwise dispose of any of the Purchased Assets, except sales or dispositions
or Encumbrances in the ordinary course of business consistent with past
practice;
(d) incur
any
indebtedness for borrowed money or guarantee any such indebtedness of another
Person, issue or sell any debt securities or warrants or other rights to acquire
any debt securities of Seller, guarantee any debt securities of another Person,
or enter into any arrangement having the economic effect of any of the
foregoing, except for borrowings incurred in the ordinary course of business
consistent with past practice;
(e) enter
into, amend, modify or terminate any Assumed Contract, except for immaterial
changes made in the ordinary course of business;
(f) adopt
a
plan of complete or partial liquidation or resolutions providing for or
authorizing such a liquidation or dissolution, merger, consolidation,
restructuring, recapitalization or reorganization;
(g) settle
or
compromise any litigation related to the Purchased Assets in which Seller is
a
defendant (whether or not commenced prior to the date of this Agreement) or
settle, pay or compromise any claims not required to be paid;
(h) modify
or
amend any existing insurance policy with respect to the Purchased
Assets;
(j) take
any
action that would reasonably be likely to have a Seller Material Adverse Effect;
or
(k) authorize
any of, or commit or agree to take any of the foregoing actions.
29
8.2 Notice
of Developments.
Seller
and Buyer will give prompt written notice to the other of: (a) the occurrence
or
nonoccurrence subsequent to the date hereof of any event the occurrence or
nonoccurrence of which would reasonably be expected to cause any representation
or warranty of such parties contained in this Agreement to be materially untrue
or inaccurate, or (b) any failure of Seller, on the one hand, or Buyer, on
the
other hand, materially to comply with or satisfy any covenant, condition or
agreement to be complied with or satisfied by it hereunder. No disclosure by
any
party pursuant to this Section 8.2 will be deemed to amend or supplement any
schedule or to prevent or cure any misrepresentation, breach of warranty or
breach of covenant unless such disclosure is accepted in writing by the
non-disclosing parties as an amendment or supplement to such schedule, as the
case may be, or as a waiver of any misrepresentation or breach.
8.3 No
Solicitation of Transactions.
Seller
shall not, directly or indirectly, through any director, officer, employee,
investment banker, financial advisor, attorney, accountant or other agent or
representative of Seller solicit, initiate or encourage or knowingly facilitate
(including by furnishing non-public information) any inquiries or the submission
of proposals or offers from any person relating to any acquisition or purchase
of all or any portion of the Purchased Assets (other than in the ordinary course
of business) or Business of, or any equity interest in, Seller, or any merger,
consolidation, share exchange, amalgamation, reorganization, recapitalization,
tender offer, exchange offer, business combination or other similar transaction
involving Seller, and, other than with Buyer or any of its Affiliates,
participate in any discussions or negotiations regarding, or furnish to any
other person any information with respect to, or otherwise cooperate in any
way
with, or assist or participate in, facilitate or encourage, any effort or
attempt by any other Person to do or seek any of the foregoing. Seller shall,
and shall cause any of its respective representatives or Affiliates to,
immediately cease and cause to be terminated or withdrawn any existing
negotiations with any parties conducted heretofore with respect to any of the
foregoing (other than in respect of the transactions contemplated hereby).
Seller shall, within two (2) business days, notify Buyer if any such proposal
or
offer, or any inquiry or contact with any person with respect thereto, is made
and shall, in any such notice to Buyer, indicate in reasonable detail the
identity of the offeror and the terms and conditions of any proposal or
offer.
8.4 Employee
Matters.
(1)
On
the
Closing Date, those employees of Seller listed on Schedule 8.4 (the “Transferred
Employees”) shall be offered employment by Buyer with such employment to be
effective as of the Closing Date on terms as agreed between Buyer and each
of
such parties. Under the eligibility and vesting provisions of all employee
benefits plans of Buyer, to the extent applicable, Buyer shall grant all
Transferred Employees on the Closing Date credit for service with Seller. Buyer
shall not assume, and Seller shall be fully responsible for the payment of,
any
severance or other benefits related to or payable upon the termination of any
of
the Transferred Employees. Seller shall have provided to Buyer accurate and
complete copies of the personnel records of the Transferred Employees. Seller
shall be responsible for compliance with all Laws required by it related to
the
termination by Seller of the Transferred Employees.
30
(2)
As
of the
Closing Date, all Transferred Employees who accept employment with Buyer shall
cease to be covered as active employees under the Seller Employee Benefit Plans
in accordance with the terms thereof except as otherwise required under
applicable Law. Buyer shall not establish, assume, maintain, contribute to
or
have any obligation to contribute to any Seller Employee Benefit Plan. Seller
shall defend and promptly indemnify Buyer in accordance with Section 11 from
and
against any and all Claims arising out of or relating to, directly or
indirectly, any Seller Employee Benefit Plan.
(3)
Seller
shall retain and be responsible for all liabilities in connection with claims
incurred prior to the Closing Date by employees and other current and former
employees of Seller associated with the Business prior to the Closing Date
and
their eligible dependents under any Seller Employee Benefit Plan, including
claims filed following the Closing Date. Buyer shall be responsible for all
liabilities in connection with claims incurred on and after the Closing Date
by
any employees hired by Buyer under any of Buyer's employee benefit plans. For
purposes of this Section 8.4, a claim shall be incurred on the date treatment
or
service is first rendered.
(4)
Nothing
in this Agreement is intended to confer on any entity or individual who is
not a
party to this Agreement (including employees) any rights
whatsoever.
(5)
Seller
shall continue to pay the salary of and provide benefits to each of the
Transferred Employees between the date hereof and the Closing Date. Seller
shall
cause each of the Transferred Employees to participate in the FDA audit referred
to in Section 9.1(5) to the extent necessary.
8.5 Pre-Closing
Tax Returns.
Seller
shall file all Tax Returns with respect to the Purchased Assets for all periods
ending on or prior to the Closing Date.
8.6 Cooperation
on Tax Matters.
Seller
and Buyer shall cooperate fully, as and to the extent reasonably requested
by
the other party, in connection with the filing of Tax Returns pursuant to this
Agreement and any audit, litigation or other Proceeding with respect to Taxes.
Such cooperation shall include the retention and (upon the other party’s
request) the provision of records and information which are reasonably relevant
to any such audit, litigation or other Proceeding and making employees available
on a mutually convenient basis to provide additional information and explanation
of any material provided hereunder. Seller shall retain all books and records
with respect to Tax matters pertinent to Seller relating to any Tax period
beginning before the Closing Date until the expiration of the statute of
limitations (including any applicable extensions) of the respective Tax periods,
and to abide by all record retention agreements entered into with any
governmental authority.
8.7 Legal
Conditions to Transaction.
Each of
the parties hereto shall take commercially reasonable actions necessary to
comply promptly with all legal requirements which may be imposed on such party
with respect to the transactions contemplated by this Agreement, and in
connection therewith shall promptly cooperate with and furnish information
to
each other in connection with any such requirements imposed upon either of
them
or any of their Subsidiaries in connection with the transactions contemplated
by
this Agreement. Each of the parties hereto shall (i) take commercially
reasonable actions necessary to obtain (and shall cooperate with each other
in
obtaining) any Consent of, or any exemption by, any governmental authority
or
other third party, required to be obtained or made by Seller for any of the
conditions set forth in Section 9 to be satisfied (any of the foregoing, an
“Approval”).
31
8.8 Form
8-K Obligations.
To the
extent required, in connection with Buyer’s financial reporting requirements
under Rule 3-05 of Regulation S-X (on Form 8-K or Form 8-K/A), Seller
agrees, at Buyer’s expense, to take such action as may be reasonably requested
to provide Buyer with access and timely assistance to examine and make copies
of, all books and records of Seller relating to the Purchased Assets, and shall
authorize its auditors, at Buyer’s expense, to provide Buyer all work papers
related to the Purchased Assets.
8.9 Use
of
Names.
Beginning immediately after the Closing Date, Seller shall cease all use of
all
corporate names, fictitious names, product names and other names used by Seller
at any time on or before the Closing Date and included in the Purchased Assets,
except as may be necessary to perform their obligations hereunder. Upon Buyer’s
request, Seller shall promptly sign all Consents and other Documents that may
be
necessary to allow Buyer to use or appropriate the use of any name used by
Seller at any time on or before the Closing Date.
8.10 Contract
Matters.
Effective as of the Closing Date, each Assumed Contract (“Transferred Contract”)
as to which (a) the Contract Rights of Seller are included in the Purchased
Assets, and (b) Consent to the assignment thereof from Seller to Buyer may
be required under such Transferred Contract or applicable Law but was not
obtained on or before the Closing Date, shall be handled in accordance with
the
following provisions:
(1)
Subcontracting.
Effective as of the Closing Date, Seller shall make available to Buyer all
Contract Rights and other benefits of such Transferred Contract, on a
subcontract or sublease basis or in some other appropriate manner to the fullest
extent possible, and Buyer shall be considered an independent subcontractor
or
sublessee of Seller, or an agent of Seller, with respect to all matters
concerning such Transferred Contract. Without limiting the foregoing, Buyer
shall be considered Seller’s agent for purposes of (a) collecting all
amounts that may be due from the other party or parties to such Transferred
Contract and (b) negotiating or otherwise handling all disputes and issues
that may arise in connection with such Transferred Contract. Until Consent
to
assignment of each Transferred Contract is obtained, Buyer shall use
commercially reasonable efforts to perform in accordance with the provisions
of
such Transferred Contract. Buyer shall be entitled to retain all payments due
from the other party or parties under the Transferred Contracts. Without Buyer’s
prior written consent, Seller shall not agree to any amendment, modification,
extension, renewal, termination or other change in the terms of such Transferred
Contract, nor shall Seller exercise any Contract Right under such Transferred
Contract.
(2)
Buyer’s
Instructions.
At
Buyer’s direction, Seller shall (a) notify the other party or parties to
such Transferred Contract that Buyer is Seller’s subcontractor, sublessee or
agent with respect thereto and that all further payments, notices and other
communications with respect thereto shall be directed to Buyer; (b) agree
to such amendments, modifications, extensions, renewals, terminations or other
changes in the terms of such Transferred Contract as Buyer determines, in its
sole discretion, are advisable; and (c) exercise any Contract Right under
such Transferred Contract at such time and in such manner as Buyer determines,
in its sole discretion, to be advisable.
32
(3)
Collateral
Assignment.
Effective as of the Closing Date, Seller hereby collaterally assign to Buyer
(except and only to the extent that such collateral assignment is expressly
prohibited by the terms of such Transferred Contract and such prohibition is
not
rendered ineffective by the Uniform Commercial Code or other applicable Law),
and grants to Buyer a security interest in, all of Seller’s Contract Rights
under such Transferred Contract and all cash and non-cash proceeds thereof,
as
security for the prompt and timely satisfaction and performance of Seller’s
obligations under this Section 8.10. Buyer shall have, and Seller shall deliver
to Buyer at the Closing, possession of the original executed copy of such
Transferred Contract. Effective as of the Closing Date, Seller hereby appoint
Buyer as Seller’s attorney to take such actions, in Seller’s names and on their
behalf, as such attorney determines, in its sole discretion, to be necessary
or
advisable to protect, perfect and continue perfected the security interest
granted hereunder including the execution and filing of such financing
statements and other Documents as such attorney determines, in its sole
discretion, to be necessary or advisable for such purposes.
(4)
Receipt
of Benefits.
Buyer
shall have no Liabilities to assume or be responsible for any obligations
pursuant to any Transferred Contract unless Buyer receives the Contract Rights
or other benefits of such Transferred Contract.
8.11 Sale
of Shares Pursuant to Rule 144 by the Seller.
If
Seller desires to sell any Shares pursuant to the provisions of Rule 144
promulgated by the SEC pursuant to §4(1) of the Securities Act, Seller shall, at
its own cost, provide Buyer with an opinion of counsel reasonably acceptable
to
Buyer that such sale is permissible under Rule 144. If Buyer’s counsel concurs
that such sale is permissible under Rule 144, Buyer shall, at its own cost,
provide an opinion of counsel in connection with the sale of such Shares by
Seller as may be required by the Company’s transfer agent in order to effectuate
the sale of such Shares. Any such sale shall be conditioned upon the retention,
if required by applicable law, of an appropriate restrictive legend on the
certificates representing the Shares sold and related stop transfer
orders.
8.12 Accounts
Receivable.
Buyer
and
Seller acknowledge and agree that all accounts receivable under the Assumed
Contracts accruing for periods through the Closing Date are for the account
of
Seller, even if such amounts are not required to be paid by the licensees until
after the Closing. Buyer will use its reasonable best efforts to collect such
accounts receivable amount on behalf of Seller and upon collection by Buyer
of
any such amounts, Buyer will hold such amounts in trust for Seller and will
pay
such amounts to Seller not later than ten (10) days following receipt thereof.
On
or
immediately following the Closing, Seller shall deliver to Buyer a list of
existing accounts receivable under the Assumed Contracts together
with
evidence
of such accounts receivable and any amounts collected by Buyer from such
customer (or successor in interest) shall be paid to Seller until such account
receivable is satisfied.
8.13 Server
Agreement.
For a
period of thirty (30) days from the Closing Date, Seller shall keep in full
force and effect and shall not terminate, nor take or fail to take any action
which would have the effect of terminating, the agreement for the rental of
space where Seller’s servers are located. Buyer shall reimburse Seller for all
amounts incurred pursuant to such agreement in order to comply with this Section
8.13 within five (5) days after receipt of a written statement from Seller
which
sets forth in reasonable detail the amounts paid.
33
8.14 Employee
Laptop Computers.
Prior
to Closing, Seller shall (i) copy and store for delivery to Buyer as part of
the
Purchased Assets, all computer files containing any information related to
the
Business or the Purchased Assets that is located on a laptop computer which
is
an Excluded Asset and (ii) after a copy of such information has been retained
for delivery to Buyer, delete such information from all laptop computers which
are Excluded Assets.
9. Conditions
to Closing.
9.1 Conditions
to Obligations of Buyer.
The
obligations of Buyer to consummate the transactions provided herein shall be
subject to the satisfaction or waiver of the following conditions:
(1)
There
shall not have occurred from the date hereof until the Closing Date, a Seller
Material Adverse Effect;
(2)
The
representations and warranties set forth in Section 4 shall be true and correct
in all material respects (without giving effect to any limitations as to
“materiality” set forth therein) at and as of the Closing Date as though then
made, except that any such representation or warranty made as of a specified
date (other than the date hereof) shall only need to have been true on and
as of
such date;
(3)
Seller
shall have performed in all material respects all of the obligations, covenants
and agreements required to be performed and complied with by it under this
Agreement prior to the Closing;
(4)
Buyer
shall have received from Seller a duly executed copy of each Transaction
Document to which Seller is a party;
(5)
Seller
shall have completed the FDA inspection scheduled to take place during the
week
of July 7, 2008 without an indication by the auditor, in an exit discussion
with
representatives of Buyer and Seller, of serious Form 483 findings which would
have a material impact on the ability of Buyer to sell the CAD Products of
Seller in the U.S. market, or that the auditor intends to recommend to the
FDA
that it take any one or more of the following actions: injunction, detention,
seizure, civil penalty prosecution and/or issuance of a warning letter, in
a
manner which would have a material impact on the ability of Buyer to sell the
CAD Products of Seller in the U.S. market;
(6)
Buyer
shall be reasonably satisfied with the results of its due diligence
investigation of Seller with respect to all Assumed Contracts that are customer
contracts;
(7)
The
Transferred Employees shall still be employed by Seller on the Closing
Date;
34
(8)
Seller
shall have obtained, or caused to be obtained, the Consent and Approval set
forth on Schedule 9.1(8);
(9)
Seller’s
server which contains Seller’s clinical and quality data shall be repaired and
in good working order or Seller shall have delivered such data to Buyer in
another medium;
(10)
There
shall not be instituted or pending any Proceeding (i) challenging or seeking
to
make illegal, or to delay or otherwise directly or indirectly restrain or
prohibit, Seller’s consummation of the transactions contemplated hereby or
seeking to obtain material damages in connection with such transactions, (ii)
seeking to prohibit direct or indirect ownership or operation by Buyer of all
or
a material portion of the Purchased Assets, or to compel Buyer or any of its
Subsidiaries to dispose of or to hold separately all or a material portion
of
the business or assets of Buyer and its Subsidiaries, as a result of the
transactions contemplated hereby, (iii) seeking to invalidate or render
unenforceable any material provision of this Agreement or any of the other
agreements attached as exhibits hereto or (iv) otherwise relating to and
materially adversely affecting the transactions contemplated hereby;
and
(11)
There
shall not be any action taken, or any Law or Judgment enacted, entered,
enforced, promulgated, issued or deemed applicable to the transactions
contemplated hereby by any governmental authority which would reasonably be
expected to result, directly or indirectly, in any of the consequences referred
to in Section 9.1(10) hereof.
9.2 Conditions
to Obligations of Seller.
The
obligations of Seller to consummate the transactions provided herein shall
be
subject to the satisfaction or waiver of the following conditions:
(1)
The
representations and warranties set forth in Section 5 hereof will be true and
correct in all material respects (without giving effect to any limitations
as to
“materiality” set forth therein) at and as of the Closing as though then made,
except that any such representation or warranty made as of a specified date
(other than the date hereof) shall only need to have been true on and as of
such
date;
(2)
Buyer
shall have performed in all material respects all the obligations, covenants
and
agreements required to be performed by it under this Agreement prior to the
Closing;
(3)
Seller
shall have received from Buyer a duly executed copy of each Transaction Document
to which Buyer is a party;
(4)
There
shall not be threatened, instituted or pending any Proceeding (i) challenging
or
seeking to make illegal, or to delay or otherwise directly or indirectly
restrain or prohibit, the consummation of the transactions contemplated hereby
or seeking to obtain material damages in connection with such transactions,
(ii)
seeking to invalidate or render unenforceable any material provision of this
Agreement or any of the Transaction Documents, or (iii) otherwise relating
to
and materially adversely affecting the transactions contemplated hereby;
and
35
(5)
There
shall not be any action taken, or any Law or Judgment enacted, entered,
enforced, promulgated, issued or deemed applicable to the transactions
contemplated hereby by any Governmental Entity which would reasonably be
expected to result, directly or indirectly, in any of the consequences referred
to in Section 9.2(4) hereof.
10. Interpretation
and Survival of Representations and Warranties.
Buyer
and Seller have the right to rely fully upon the representations, warranties,
covenants and agreements contained in this Agreement or in any Transaction
Document delivered to them or any representatives in connection with the
transactions contemplated by this Agreement. Each warranty, representation
and
covenant contained herein is independent of all other warranties,
representations and covenants contained herein (whether or not covering
identical or related subject matter) and must be independently and separately
complied with and satisfied or waived. All representations, warranties,
covenants and agreements shall survive the execution and delivery hereof and
the
Closing hereunder. Notwithstanding the foregoing:
10.1 the
representations and warranties of Seller contained in Sections 4.1 (Due
Organization and Qualification; Subsidiaries), 4.2 (Authority to Execute and
Perform Agreement), 4.5 (Tax Matters), 4.16 (Title), and 4.25 (No Broker) of
this Agreement (collectively the “Fundamental Representations”); the
representations and warranties of Buyer contained in Sections 5.1 (Due
Incorporation and Qualification), 5.2 (Authority to Execute and Perform
Agreement), 5.4 (No Broker), 5.5 (Capitalization) and 5.7 (Issuance of Buyer’s
Stock) of this Agreement and the respective covenants and agreements of the
parties hereto contained in this Agreement; and the related agreements of Seller
and Buyer to indemnify each other set forth in Section 11, shall survive the
Closing and continue in full force and effect shall survive until sixty (60)
days after the expiration of the applicable statute of limitations for the
applicable underlying claim, including any extensions or waivers thereof and
any
claims in connection with fraud shall survive indefinitely; and
10.2 all
other
representations and warranties of Seller and Buyer hereunder, and the related
agreements of Seller and Buyer to indemnify each other set forth in Section
11,
shall survive the Closing and continue in full force and effect until, and
all
indemnification claims with respect thereto shall be made prior to,
the twelfth
(12th) month after the Closing Date, except for representations, warranties
and
related indemnities for which an indemnification claim shall be pending as
of
the end of the applicable period referred to above, in which event such
indemnities shall survive with respect to such indemnification claim until
the
final disposition thereof.
11. Indemnification.
11.1 Obligation
of Seller to Indemnify.
Seller
shall indemnify, defend and hold harmless Buyer and its officers, directors,
shareholders and Affiliates (collectively, the “Buyer Indemnified Parties”) from
and against any and all Losses with respect to the following:
(1)
any
misrepresentation or breach of any representation, warranty, covenant or
agreement of Seller contained in this Agreement or in any Transaction Document
delivered pursuant to this Agreement;
36
(2)
any
breach of or failure to perform any covenant, agreement or obligation of either
Seller contained in this Agreement or in any other Transaction
Document;
(3)
any
Retained Liabilities; and/or
(4)
any
actions, causes of action, claims, suits, Proceedings, demands, assessments,
settlements, Judgments, damages, Losses, costs and legal and other expenses
incident to any of the foregoing.
11.2 Obligation
of Buyer to Indemnify.
Buyer
shall indemnify, defend and hold harmless Seller and their respective officers,
directors, membership interest owners and Affiliates (collectively, the "Seller
Indemnified Parties") from and against any and all Losses with respect to the
following:
(1)
any
breach of any representation or warranty of Buyer contained in this Agreement
or
in any other Transaction Document;
(2)
any
breach of or failure to perform any covenant, agreement or obligation of Buyer
contained in this Agreement or in any other Transaction Document;
and/or
(3)
the
Specified Liabilities.
11.3 Third
Party Claims.
If a
claim by a third party is made against any party or parties hereto and the
party
or parties against whom said claim is made intends to seek indemnification
with
respect thereto under Sections 11.1 or 11.2, the party or parties seeking such
indemnification shall promptly notify the indemnifying party or parties, in
writing, of such claim; provided, however, that the failure to give such notice
shall not affect the rights of the indemnified party or parties hereunder except
to the extent that such failure materially and adversely affects the
indemnifying party or parties due to the inability to timely defend such action.
The indemnifying party or parties shall have ten (10) business days after said
notice is given to elect, by written notice given to the indemnified party
or
parties, to undertake, conduct and control, through counsel of their own
choosing (subject to the consent of the indemnified party or parties, such
consent not to be unreasonably withheld) and at their sole risk and expense,
the
good faith settlement or defense of such claim, and the indemnified party or
parties shall cooperate with the indemnifying parties in connection therewith;
provided: (a) all settlements require the prior reasonable consultation with
the
indemnified party and the prior written consent of the indemnified party, which
consent shall not be unreasonably withheld, and (b) the indemnified party or
parties shall be entitled to participate in such settlement or defense through
counsel chosen by the indemnified party or parties, provided that the fees
and
expenses of such counsel shall be borne by the indemnified party or parties.
So
long as the indemnifying party or parties are contesting any such claim in
good
faith, the indemnified party or parties shall not pay or settle any such claim;
provided, however, that notwithstanding the foregoing, the indemnified party
or
parties shall have the right to pay or settle any such claim at any time,
provided that in such event they shall waive any right of indemnification
therefor by the indemnifying party or parties. If the indemnifying party or
parties do not make a timely election to undertake the good faith defense or
settlement of the claim as aforesaid, or if the indemnifying parties fail to
proceed with the good faith defense or settlement of the matter after making
such election, then, in either such event, the indemnified party or parties
shall have the right to contest, settle or compromise (provided that all
settlements or compromises require the prior reasonable consultation with the
indemnifying party and the prior written consent of the indemnifying party,
which consent shall not be unreasonably withheld) the claim at their exclusive
discretion, at the risk and expense of the indemnifying parties.
37
11.4 Limitation
of Liability.
Notwithstanding the foregoing, neither party subject to this Agreement shall
be
liable pursuant to this Section 11 until the aggregate amount otherwise due
the
Buyer Indemnified Parties or the Seller Indemnified Parties, as the case may
be,
equals or exceeds an accumulated total of $50,000. Once such claims equal or
exceed the $50,000 threshold, the Buyer Indemnified Parties or the Seller
Indemnified Parties, as the case may be, will be entitled to the full amount
of
all indemnified claims in excess of such $50,000, provided however, that the
limitations set forth in this Section 11.4 shall not apply to indemnification
claims arising from (A) any breach of any Fundamental Representation,
(B) any covenants made by either party to this Agreement herein,
(C) the Retained Liabilities or (D) any acts of fraud, intentional
misrepresentation or willful misconduct of either party to this
Agreement.
11.5 Satisfaction
of Seller Losses.
In the
event that Seller is required to indemnify any Buyer Indemnified Party for
any
Losses under this Section 11, Seller shall have the option to elect to satisfy
such Losses either (i) in cash or (ii) by the return of Escrow Shares. The
number of the Escrow Shares to be returned to satisfy any such Losses shall
be
valued as determined in clause (ii) of Section 3.2.
11.6 Assistance.
Regardless of which party is controlling the defense of any claim, each party
shall act in good faith and shall provide reasonable documents and cooperation
to the party handling the defense.
12. Expenses.
Whether
or not the transactions contemplated by this Agreement shall be consummated,
each party shall pay its own expenses incident to preparing for, entering into
and carrying into effect this Agreement and the transactions contemplated
hereby. Buyer shall be responsible for and make arrangements to pay all sales,
transfer, stamp, recording and similar Taxes, if any, incurred in connection
with any Intangibles and Tangible Property conveyed to Buyer
hereunder.
13. Termination
and Abandonment.
13.1 Ability
to Terminate.
This
Agreement may be terminated at any time prior to the Closing:
(1)
by
mutual
written consent of Buyer and Seller;
(2)
by
either
Buyer or Seller if any court of competent jurisdiction in the United States
or
other United States governmental authority shall have issued a final order,
decree or ruling or taken any other final action restraining, enjoining or
otherwise prohibiting the consummation of the transactions contemplated by
this
Agreement and such order, decree, ruling or other action is or shall have become
final and nonappealable;
38
(3)
by
either
Buyer or Seller, if there has been a material breach on the part of the other
of
any representation, warranty, covenant or agreement contained in this Agreement
which would result in the breaching party’s inability to meet the conditions set
forth in Section 9 hereof;
(4)
by
Buyer,
if after the date hereof, there shall have been a Seller Material Adverse
Effect;
(5)
by
Seller, if after the date hereof, there shall have been a Buyer Material Adverse
Effect;
(6)
by
Buyer
if the results of the FDA audit result in any of the specified actions set
forth
in Section 9.1(5); or
(7)
by
Seller, if the Closing has not occurred within twenty days of the completion
of
the field work in connection with the FDA inspection referred to in Section
9.1(5).
13.2 Effect
of Termination.
The
termination of this Agreement shall be effectuated by the delivery by the party
terminating this Agreement to the other party of a written notice of such
termination. In the event of termination of this Agreement by either Buyer
or
Seller pursuant to this Section 13.2, this Agreement shall forthwith become
void
and there will be no liability under this Agreement on the part of either party,
except (i) to the extent that such termination results from the willful and
material breach by a party of any of its representations, warranties, covenants
or agreements set forth in this Agreement and (ii) Section 12 (Expenses),
Section 15 (Confidentiality), and this Section 13 will remain in full force
and
effect and will survive any termination of this Agreement.
14. Further
Assurances.
14.1 At
any
time and from time to time after the Closing Date, at Buyer’s request and
without further consideration, Seller will promptly execute and deliver all
such
further Documents or perform such acts as Buyer may reasonably request in order
to more fully consummate the transactions contemplated herein and in order
to
more effectively vest, transfer, confirm, protect and defend the right, title
and interest of Buyer in the Purchased Assets and to assist Buyer in exercising
its rights and privileges with respect thereto.
14.2 After
the
Closing Date, Seller shall do the following:
(1)
Deliver
to Buyer all notices, correspondence and other items relating to the Purchased
Assets which are from time to time received by them or are in their
possession.
(2)
File
with
the appropriate governmental body documents sufficient to effect a change of
each Seller’s name to one not similar to its current name and send proof of such
filing and proper advertising thereof to Buyer, and file with each jurisdiction
in which Seller is licensed or qualified to do business such Documents as are
necessary to effectuate such change of name in each such
jurisdiction.
39
15. Confidentiality.
Without
the prior written Consent of the other parties, neither Buyer nor Seller shall,
nor shall they permit any of their respective Affiliates to, disclose any
confidential information of the other party, and shall comply with, and cause
their respective representatives to comply with, all of their respective
obligations under that certain the Confidentiality and Non-Disclosure Agreement
dated April 23, 2007, previously executed by Buyer and Seller (the
“Confidentiality Agreement”). Notwithstanding anything contained herein or in
the Confidentiality Agreement, Seller shall be relieved of its obligations
thereunder effective June 30, 2011.
16. Non-Compete.
16.1 Seller
hereby agrees for a period of five (5) years after the Closing Date, not to,
directly or indirectly, within any State within the United States, or any other
geographic area in which Buyer or any of its Subsidiaries then conducts
business, (i) engage or become interested in any business (whether as
owner, manager, operator, licensor, licensee, lender, guarantor partner,
stockholder, joint venturer, employee, consultant or otherwise) or render any
services to any business competitive with the Business or any business of Buyer
and its Subsidiaries as of the Closing Date other than as a holder for
investment purposes only of not more than one percent (1%) of the
publicly-traded capital stock of any corporations engaged in such businesses,
(ii) conduct any business, directly or indirectly, using any of Seller’s
corporate names or any other trade names of Seller in existence as of the
Closing Date, or (iii) take any other action which constitutes an
interference with or a disruption of Buyer’s operation of the Business or
Buyer’s use, ownership and enjoyment of the Purchased Assets after the Closing
Date. At no time shall Seller, directly or indirectly, disparage the commercial,
business or financial reputation of Buyer or any of its Subsidiaries.
16.2 For
purposes of clarification, but not of limitation, Seller acknowledges and agrees
that the provisions of Section 16.1 above shall serve as a prohibition against
it, during the period described therein, directly or indirectly, hiring,
offering to hire, enticing away or in any other manner persuading or attempting
to persuade any officer, employee, agent, lessor, lessee, licensor, licensee,
customer, prospective customer or supplier of the Business or any business
of
Buyer and its Subsidiaries to discontinue or alter his or its relationship
with
such business.
16.3 The
parties hereto hereby acknowledge and agree that (i) Buyer would be
irreparably injured in the event of a breach by Seller of any of its obligations
under this Section 16, (ii) monetary damages would not be an adequate
remedy for any such breach, and (iii) Buyer shall be entitled to injunctive
relief, in addition to any other remedy which it may have, in the event of
any
such breach. It is hereby also agreed that the existence of any claims which
Seller may have against Buyer, whether under this Agreement or otherwise, shall
not be a defense to the enforcement by Buyer of any of the rights under this
Section 16.
40
16.4 It
is the
intent of the parties hereto that the covenants contained in this Agreement
shall be enforced to the fullest extent permissible under the laws of and public
policies of each jurisdiction in which enforcement is sought (Seller hereby
acknowledges that said restrictions are reasonably necessary for the protection
of Buyer). Accordingly, it is hereby agreed that if any one or more of the
provisions of Section 16 shall be adjudicated to be invalid or unenforceable
for
any reason whatsoever, said provision shall be (only with respect to the
operation thereof in the particular jurisdiction in which such adjudication
is
made) construed by limiting and reducing it so as to be enforceable to the
extent permissible.
16.5 The
provisions of this Section 16 shall be in addition to, and not in lieu of,
any
other obligations with respect to the subject matter hereof, whether arising
as
a matter of contract, by law or otherwise.
17. Bulk
Sales Compliance.
Buyer
hereby waives compliance by Seller with all Laws relating to bulk sales and/or
the sale and purchase of the Purchased Assets in each applicable jurisdiction.
Seller will indemnify and hold Buyer harmless from, against and with respect
to,
and shall reimburse Buyer for any and all Losses suffered or incurred by Buyer
arising out of, relating to or by reason of any noncompliance with such
Laws. This indemnification shall apply to, but shall not be limited to, Losses
due to any acceleration of payment with respect to any Liability or obligation
of Seller assumed by Buyer hereunder, and is in addition to the indemnification
provided pursuant to Section 11.
18. Miscellaneous.
18.1 Publicity.
The
parties shall consult with each other before issuing any press release with
respect to the Agreement or the transactions contemplated hereby and shall
not
issue any such press release or make any such public statement without the
prior
consent of the other parties, which shall not be unreasonably withheld,
conditioned or delayed; provided,
however,
that
Buyer may, without the prior consent of the other parties (but after prior
consultation, to the extent practicable in the circumstances) issue such press
release or make such public statement as may upon the advice of outside counsel
be required by law or the rules and regulations of NASDAQ.
18.2 Notices.
Any
notice or other communication required or which may be given hereunder shall
be
in writing and either delivered personally to the addressee, or mailed,
certified or registered mail or express mail, postage prepaid, or sent by a
nationally recognized courier service, service charges prepaid, and shall be
deemed given when so delivered personally, if by certified or registered mail,
four days after the date of mailing or if express mailed or sent by a nationally
recognized courier service, two (2) days after the date of mailing, as
follows:
(1)
If
to
Buyer:
iCAD,
Inc.
00
Xxxx
Xxxxx Xxxx, Xxxxx 000
Xxxxxx,
Xxx Xxxxxxxxx 00000
Attention:
|
Xxxxxxx
Xxxxx, President and
Chief
Executive Officer
|
41
With
a
required copy to:
Blank
Rome LLP
000
Xxxxxxxxx Xxxxxx
Xxx
Xxxx,
Xxx Xxxx 00000
Attention:
Xxxxxx X. Xxxxxxx, Esq.
(2)
If
to
Seller:
3TP
LLC
0
Xxxxxxx
Xxxx Xxxxx
Xxxxxxxxx,
Xxxxxxxxxxx 00000
With
a
required copy to:
Xxxxx
& Xxx Xxxxxx LLP
0
Xxxx
Xxxxxx
Xxx
Xxxx,
Xxx Xxxx 00000
Attention:
Xxxxxxx X. XxXxxx, Esq.
and
to
such other address or addresses as Buyer or Seller, as the case may be, may
designate to the other by notice as set forth above.
18.3 Entire
Agreement.
This
Agreement (including the Exhibits and Schedules hereto) and the Confidentiality
Agreement contains the entire agreement among the parties with respect to the
subject matter hereof and supersedes all prior or contemporaneous agreements,
written or oral, with respect thereto.
18.4 Waivers
and Amendments.
This
Agreement may be amended, modified, superseded or cancelled and the terms and
conditions hereof may be waived, only by a written instrument signed by all
the
parties or, in the case of a waiver, by the party waiving compliance. No delay
on the part of any party in exercising any right, power or privilege hereunder
shall operate as a waiver thereof, nor shall any waiver on the part of any
party
of any right, power or privilege hereunder, nor shall any single or partial
exercise of any right, power or privilege hereunder preclude any other or
further exercise thereof or the exercise of any other right, power or privilege
hereunder. The rights and remedies herein provided are cumulative and are not
exclusive of any rights or remedies which any party may otherwise have at law
or
in equity. The rights and remedies of any party arising out of or otherwise
in
respect of any inaccuracy in or breach of any representation, warranty, covenant
or agreement contained in this Agreement shall in no way be limited by the
fact
that the act, omission, occurrence, or other state of facts upon which any
claim
of any such inaccuracy or breach is based may also be the subject matter of
any
other representation, warranty, covenant or agreement contained in this
Agreement (or in any other agreement between the parties) as to which there
is
no inaccuracy or breach.
42
18.5 Binding
Agreement.
All of
the terms and provisions of this Agreement shall be binding upon, inure to
the
benefit of and be enforceable by each of the parties hereto and their respective
heirs, legal representatives, executors, successors and assigns.
18.6 Governing
Law.
This
Agreement shall be governed and construed in accordance with the laws of the
State of Delaware, without regard to its conflicts of laws
provisions.
18.7 Assignment.
This
Agreement and the rights and obligations of the parties hereto shall not be
assigned by any party to any Person without the prior written consent of the
other party. Nothing in this Agreement, unless otherwise expressly provided,
is
intended to confer upon any Person, other than the parties hereto and their
successors and assigns, any rights or remedies under or by reason of this
Agreement.
18.8 Variations
in Pronouns.
All
pronouns and any variations thereof refer to the masculine, feminine or neuter,
singular or plural, as the identity of the person or persons may
require.
18.9 Disclosure
Schedules.
Disclosures included in any Section of the Disclosure Schedules shall be
considered to be made for purposes of all other Sections of the Disclosure
Schedules to the extent that the relevance of any such disclosure to any other
Section of the Disclosure Schedules is reasonably apparent from the text of
such
disclosure.
18.10 Severability.
If any
provision of this Agreement shall be determined by a court of competent
jurisdiction to be invalid or unenforceable, such determination shall not affect
the remaining provisions of this Agreement, all of which shall remain in full
force and effect.
18.11 Counterparts.
This
Agreement may be executed in two or more counterparts, each of which shall
be
deemed an original but all of which together shall constitute one and the same
instrument.
18.12 Exhibits
and Schedules.
The
Exhibits and Schedules to this Agreement are a part of this Agreement as if
set
forth in full herein.
18.13 Headings.
The
headings in this Agreement are for reference purposes only and shall not in
any
way affect the meaning or interpretation of this Agreement.
43
18.14 Consent
to Jurisdiction and Service of Process.
Any
Proceeding arising out of or relating to this Agreement or the transactions
contemplated hereby may be instituted in any state or federal court in the
State
of New Hampshire, applying the laws of the State of Delaware without giving
effect to its conflict of laws principles, and each party waives any objection
which such party may now or hereafter have to the laying of the venue of any
such Proceeding, and irrevocably submits to the jurisdiction of any such court
in any such Proceeding. Any and all service of process and any other notice
in
any such Proceeding shall be effective against any party if given by registered
or certified mail, return receipt requested, or by any other means of mail
which
requires a signed receipt, postage prepaid, mailed to such party as herein
provided. Nothing herein contained shall be deemed to affect the right of any
party to serve process in any manner permitted by law or to commence legal
Proceedings or otherwise proceed.
[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK]
44
IN
WITNESS WHEREOF, the parties have executed this Agreement as of the date first
above written.
BUYER:
|
SELLER:
|
|||
iCAD,
INC.
|
3TP
LLC
|
|||
By:
|
/s/
Xxxxxxx Xxxxx
|
By:
|
/s/
Xxxxxxx X. Xxxxxx
|
|
Name:
Xxxxxxx Xxxxx
|
Name:
Xxxxxxx X. Xxxxxx
|
|||
Title:
CEO
|
Title:
Chief Executive Office
|
45
LIST
OF
OMITTED EXHIBITS AND SCHEDULES
Exhibit
|
Description
|
Exhibit
A
|
Escrow
Agreement
|
Exhibit
B
|
Xxxx
of Sale
|
Exhibit
C
|
Master
Trademark Assignment Agreement
|
Exhibit
D
|
Master
Patent Assignment Agreement
|
Exhibit
E
|
510(k)
Clearances Assignment Agreement
|
Exhibit
F
|
Assignment
and Assumption Agreement
|
Schedule
|
Description
|
Schedule
2.1(5)
|
Assumed
Contracts
|
Schedule
2.2(8)
|
Excluded
Assets
|
Schedule
2.3(2)
|
Assumed
Warranty and Service Obligations
|
Schedule
2.3(3)
|
Specified
Liabilities
|
Schedule
3.4
|
Purchase
Price Allocation
|
Schedule
4.1
|
Due
Incorporation and Qualification; Subsidiaries
|
Schedule
4.3
|
Financial
Statements
|
Schedule
4.4
|
No
Material Adverse Change
|
Schedule
4.5
|
Taxes
|
Schedule
4.6
|
Compliance
with Laws
|
Schedule
4.7
|
Permits
|
Schedule
4.8
|
No
Breach
|
Schedule
4.9
|
Consents
and Approvals
|
Schedule
4.10
|
Judgments
and Proceedings
|
Schedule
4.11
|
Contracts
|
Schedule
4.12
|
Real
Property
|
Schedule
4.14
|
Tangible
Property
|
Schedule
4.15
|
Intangibles
|
Schedule
4.16
|
Title
|
Schedule
4.17
|
Indebtedness
|
Schedule
4.19
|
Suppliers
and Customers
|
Schedule
4.22
|
Inventory
|
Schedule
4.23
|
Regulatory
Matters
|
Schedule
4.24
|
Related
Party Transactions
|
Schedule
4.25
|
No
Broker
|
Schedule
8.4
|
Transferred
Employees
|
Schedule
9.1(8)
|
Required
Consents
|
46